Regulators of hemoglobin switching in zebrafish and human models by Ganis, Jared Jason
 Regulators of hemoglobin switching in zebrafish and human models
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Ganis, Jared Jason.  2014.  Regulators of hemoglobin switching in
zebrafish and human models.  Doctoral dissertation, Harvard
University.
Accessed April 17, 2018 5:05:02 PM EDT
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:12274627
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAA
  
Regulators of hemoglobin switching in zebrafish and human models 
 
 
 
A dissertation presented  
by 
Jared Jason Ganis 
 
 
to 
The Division of Medical Sciences  
In partial fulfillment of the requirements 
for the degree of  
Doctor of Philosophy 
in the subject of  
Human Biology and Translational Medicine 
 
 
 
Harvard University 
Cambridge, Massachusetts 
April 2014  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2014 Jared Jason Ganis 
All rights reserved.
iii 
 
Dissertation Advisor: Dr. Leonard I. Zon           Jared Jason Ganis 
 
Regulators of hemoglobin switching in zebrafish and human models 
 
Abstract 
Hemoglobin switching is a developmental process involving the dynamic transcriptional 
regulation of multiple globin genes. This molecular process involves multiple layer of 
complexity, and elucidating new mechanisms in this process will result in a more complete 
understanding of general gene regulation and will likely have direct clinical implications for 
hemoglobinopathies, such as sickle cell anemia.  In this dissertation, I develop and characterize a 
new model for hemoglobin switching, the zebrafish.  I defined and fully annotated the two 
zebrafish globin loci, termed major and minor loci.  Both loci contain α- and β-globin genes 
oriented in a head-to-head fashion.  Characterization of the globin expression pattern precisely 
defined the timing of normal switching and demonstrated that zebrafish, like humans, have two 
globin switches.  The locus control region for the major locus was identified and in conjunction 
with a proximal promoter was able to generate robust, erythroid-specific expression in a 
transgenic line.   
Utilizing the zebrafish system, I performed morpholino knockdown and chemical screens 
to identify genes and pathways that increase adult globin expression in embryos, therefore 
potentially regulating globin switching.  The morpholino screen identified the combined 
knockdown of tcf7l2 and ncoa1 as causing significant temporal misexpression, and the chemical 
screen identified a number of nuclear hormone receptor pathway modulators, including T4, and 
the Wnt inhibitor XAV939.  Further testing demonstrated that the thyroid hormone receptor and 
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Wnt pathways synergize.  The thyroid hormone receptor pathway specifically increases adult 
globin expression at the mRNA and protein levels in both embryos and larva.  Conversely, 
antagonism of this pathway in the adult leads to an increase in larval and embryonic globins.  
Data from K562 and human primary fetal CD34+ cells demonstrate that the regulatory role of the 
thyroid hormone receptor pathway is conserved in mammals.  ChIP-seq analyses in the zebrafish 
and cell culture systems show that this effect is potentially directly mediated at the globin locus.  
The data presented here demonstrate that both the Wnt and thyroid hormone receptor pathways 
play a role in the regulation of hemoglobin switching and potential open new area for 
investigation into clinical treatments for hemoglobinopathies. 
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Introduction 
 
2 
 
Hemoglobin switching is a developmental process involving the dynamic transcriptional 
regulation of multiple globin genes.  This process is inextricably linked to normal development, 
particularly, of course, hematopoietic and erythroid development, which flows from the central 
role of hemoglobin in the delivery of oxygen to the tissues that are also changing throughout this 
process.  The regulation of this process is fittingly complex, and, while substantial progress has 
been made in the nearly 150 years since its discovery [1], critical questions still remain.  
Numerous models have been developed and studied to add to the general understanding of the 
process, but all have limitations.  The study of general development has uncovered numerous 
genes and pathways controlling the process, some that directly impact globin switching and other 
that have not been implicated.  Study of this process is critical not only to gain a better 
understanding of development but to potentially address diseases associated with hemoglobin 
and hemoglobin expression.   
Erythropoiesis during the Development of Mammals and the Zebrafish 
Erythropoiesis, the development of mature functional erythrocytes from precursor cells, 
is an essential function in vertebrates.  This process, however, changes to meet the changing 
needs of the organisms as it develops [2,3].  During development, erythropoiesis is separated into 
two major categories, primitive and definitive [4].  The primitive wave is characterized by 
unipotent progenitors specified from mesoderm, which occurs in the yolk sac in mammals. 
Erythrocytes and macrophages are produced during this wave in order to oxygenate and help 
remodel the embryo as it continues to develop [5]. However, this wave is transient, as primitive 
erythroid progenitors, for example, can first be detected in the mouse at embryonic day (E) 7.25 
and become undetectable after E9.0 [4]. As the vertebrate embryo continues to develop, 
hematopoietic stem cells (HSCs) are specified, and all the mature blood cells produced by these 
3 
 
HSCs compose the definitive wave of hematopoiesis [6].  HSCs emerge in the aorta-gonad-
mesonephros (AGM) region, but migrate throughout the developing embryo before homing to 
their final, adult location in the bone marrow (mammals) or kidney marrow (zebrafish) [7,8].   
The red cells produced by these two waves of hematopoiesis, while accomplishing the 
same general function, are not identical.  The size, developmental lineage, gene expression 
profile, and their sensitivity and response to cytokines vary [4,7–9].  Another, often defining, 
difference between primitive and definitive red blood cells is their globin gene expression 
profile.  In mice, humans, and zebrafish primitive cells express a different set of globin genes 
than adult, definitive red cells [4,7,9].         
Within each of these waves, red cells mature from their precursor cells into fully mature 
erythrocytes through a number of steps (proerythroblasts, basophilic erythroblasts, 
polychromatic erythroblasts, orthochromatic erythroblasts and reticulocytes) [10–12].  However, 
the location of these maturational steps (marrow in the adult; bloodstream in the embryo) and 
whether they are synchronous or not (staggered in the adult; synchronous in the embryo) vary 
[4,12].  
This complex specification and maturation is controlled and executed by a large, complex 
network of transcription factors, many of which are common to both lineages [4].  GATA1, 
considered the mater regulator of both primitive and definitive erythroid lineages, is critical for 
proper specification, maintenance and function [13].  GATA2 is also a key regulator essential for 
normal erythropoiesis [14,15].  SCL, LMO2, KLF1, and numerous other factors also play a 
direct role in the successful development of functional erythroid cells, including production of 
both the protein and heme components of hemoglobin [3,12,13,16–18].  Non-cell autonomous 
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control of erythropoiesis is mediated by cytokines, the most critical of which is erythropoietin 
(EPO).  The regulatory mechanism of EPO senses the organismal state of hypoxia, and in times 
of need, induces EPO.  This in turn increases the output of erythropoiesis to compensate [19].   
Globin expression and regulation in zebrafish and mammals 
Structure and function of hemoglobin 
Hemoglobin was first discovered in 1840 by F. L. Hünfeld as crystals forming in blood 
[20], and significant strides in our understanding of this essential protein have been made since.  
The functional unit of hemoglobin is a tetramer, composed of two α-like and two β-like protein 
components, known as globins.  Each globin carries a prosthetic heme molecule, and each heme 
group contains an iron molecule, which in turn can combine with an oxygen or carbon dioxide 
for transport throughout the organism [21].  This process allows the organism to oxygenate 
tissues not directly in contact with the atmosphere.  Cooperative binding by these tetrameric 
units aids efficient transport of oxygen from oxygen rich environments (lung/gills) to oxygen 
poor area (body tissues), and conversely for carbon dioxide [21,22].  Globin protein synthesis, as 
with all proteins, begins with transcription of mRNA from the appropriate genomic locus 
followed by translation into an amino acid chain.  However, because of the tetrameric quaternary 
structure of hemoglobin and the four prosthetic heme groups, the final functional molecule is 
only fully functional after amino acids chains generated from two distinct genomic loci and a 
complex biochemical pathway are combined [23]. 
Developmental changes in globin expression and the organismal and cellular level 
Hemoglobin switching is a developmental process involving the dynamic transcriptional 
regulation of multiple globin genes and occurs in all classes of vertebrates [24].  One reason for 
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these alterations in globin gene expression are the changing oxygen needs of organisms as they 
develop [25].  Hemoglobin switching can occur at the organismal level, the globin composition 
of the red cell compartment overall changes [4], or at the cellular level, the globin genes that an 
individual cell expresses change over the life of that cell [26].  However, whether the changes in 
signaling, transcription factor milieu, chromatin structure, or exogenous treatments exhort their 
effects on different cells or the same cell overtime, they still regulate globin gene expression and 
therefore the globin switching process.  As mentioned above, switching at the organismal level is 
often correlated to red cells derived from the primitive wave versus the definitive wave.  In both 
zebrafish and mammals, primitive erythrocytes are derived from mesoderm and transition 
through a bipotent hemangioblast stage.  In the zebrafish, primitive red cells eventually emerge 
from the region known at the intermediate cell mass (ICM), while in mammalian systems they 
arise in the yolk sac  [4,6,27].  Zebrafish red cells are thought to be the only red cells in 
circulation for the first 4 days of life [28], but may remain in circulation for more than 7 days 
[27].  Detection of primitive red cells in mammals is possible as early as embryonic day 7.5 [29].  
In both cases the red cells derived from the primitive wave express the embryonic forms of 
hemoglobin [30,31].  Definitive zebrafish and mammalian red cells differentiate from 
multipotent progenitors known as hematopoietic stem cells (HSCs), which originate in the aorta-
gonad-mesonephros (AGM) region during development.  These cells provide a consistent supply 
of red cell progenitors throughout the life of the organism that express, nearly exclusively, adult 
globin genes [31,32].  Changes at the level of individual cells, termed “maturational” globin 
switching, mainly occur within the primitive wave of mammals as individual cells mature [26].  
One or more of the differences between these developmental paths or the signals they receive 
during them results in these cell types expressing different, specific globin genes.  
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Structure, function, and cis-regulatory elements at the globin loci 
The initiation of hemoglobin production begins at a globin locus.  Globin loci are 
complex regions that contain a number of cis-regulatory elements and a number of coding globin 
genes.  The general, overarching structure and synteny of globin loci has been conserved since 
the ancestral globin locus found in early jawed vertebrates.  In humans and mice, there are two 
globin loci, one encoding the α-like globins and the other the β-like.  However, this 
organizational structure is not present in all vertebrates [33], including puffer fish which have 
two loci, but there is not a strict segregation of the α- and β-like genes.  However, synteny is 
conserved as genes flanking the human α-globin  locus are also found upstream of both puffer 
fish globin loci [34].  The number of globin genes on each locus also varies between species, 
including between mice and humans [35].  In humans and mice, these genes are all oriented in 
the same direction within the loci and organized in order in which they are developmentally 
expressed [36].            
The most critical and influential regulatory elements controlling the expression of these 
genes is a long-range enhancer known at the locus control region (LCR), which can be over 
10kbs upstream of the genes it regulates.  It promotes high levels of cell-type specific globin 
gene expression [37] and helps regulates which of the coding globin genes is actively transcribed 
at any one time [38].  The LCR is often characterized by DNase I hypersensitive sites and the 
binding of critical erythrocyte transcription factors, such as the master regulator GATA1.  DNase 
I hypersensitive sites are formed by several critical erythroid factors including GATA1, EKLF, 
and NFE2, and the erythroid-specific chromatin structure that develops is essential for proper 
function of the element in vivo [39].  This element does vary in structure in humans and mice and 
even between the two loci within a species [38,40], but it does retain many conserved functions 
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across vertebrates as well as some other species [33,41–45].  The LCR interacts directly and 
physically with the proximal globin promoters, creating a “competition” between the promoters 
for activation by the LCR [38].   
The proximal promoters regulating their respective coding genes also play an integral 
role in regulating globin expression.  The physical looping of the LCR to interact with discreet 
proximal promoters forms a structure known as an active chromatin hub [46].  This structure 
adopts different conformations and composition (i.e. which, if any, globin promoters are actively 
participating) throughout the course of the normal differentiation of erythroid cells as well as 
when different globin genes are being expressed [38,47].  While expression of globin genes can 
occur without the LCR, the LCR enhances expression 100- to 1000 fold over the proximal 
promoter alone [37,48].  In addition, the LCR cannot act to enhance the expression of the coding 
globin genes without the presence of a proximal promoter to recruit essential trans-acting 
factors.  The proper functioning of globin loci depends on features of the LCR, proximal 
promoters, and the precise orchestration of the active chromatin hub they form [36]. 
While much of the work to define the specific roles of these elements has been completed 
in model systems where the individual elements, such as individual DNase I hypersensitive sites, 
can be mutated, deleted, or otherwise disrupted and the effects on globin expression observed to 
infer their specific role(s) [37,38,40,49–52], substantial strides in our understanding of the globin 
locus has originated from work in humans.  However, in humans, such experiments can only be 
conducted through the study of naturally occurring mutations.  Both point mutation and large 
regions of deletion in the globin loci have been identified, causing a variety of phenotypes such 
as β-thalassemia, α-thalassemia, and hereditary persistence of fetal hemoglobin (HPFH).  By 
establishing and correlating the phenotypes and genotypes of these individuals, critical 
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regulatory regions and transcription factor binding sites have been identified.  While it is 
unfortunate that many of the mutations in the human globin loci lead to disease states, 
identifying and characterizing them has lead to a better understanding of globin gene regulation 
[47,51,53,54].                      
Regulation of globin switching by trans-acting factors 
While the cis-regulatory elements found at the globin locus are complex, multifunctional 
elements, they cannot fully explain globin switching.  As all red cell progenitors transcribe 
globin using the same genomic loci, some extra-genomic differences must be acting to 
selectively produce particular globin genes.  The critical role of the trans-acting environment 
was shown through early work in amphibians.  It was first shown that the external environment 
of the cell could influence the globin genes expressed by erythroid cells when transplants 
between two sites of erythropoiesis within an animal produced red cells expressing globin genes 
native to their transplanted location rather than location of origin [55].  The influence of the 
internal milieu of the cell was demonstrated with the use of heteropolykaryons, by fusing adult 
globin expressing erythroid cells with embryonic globin expressing cells from either another frog 
species or between frogs and mice.  The transacting environments stimulated the previously 
inactive globin genes [56].  The reciprocal nature of these experiments, that the embryonic 
environment could activate embryonic globins in adult cells and the adult environment could 
activate adult globins in the embryonic cells, showed the critical influence of the cellular milieu 
in controlling globin gene switching, and the ability to work across species clearly demonstrated 
the conserved nature of these pathways [56–58].  The trans-acting factors, such as transcription 
factors, act on the cis-regulatory elements that compose globin loci and modulate their function 
either directly or indirectly.   
9 
 
The presence of multiple types of hemoglobin in humans has been appreciated and 
studied for over 80 years [59], resulting in a number of advancements in our understanding of the 
what factors are involved and their mechanisms of action.  The transcription factor BCL11A has 
emerged as one of the most critical factors in globin gene regulation.  It was originally identified 
as a potential regulator because polymorphisms in the gene were associated with HPFH [60–62], 
and its role established in a number of model systems [63,64].  Sankaran et al. were able to 
establish BCL11A as a direct, influential repressor of fetal hemoglobin.  The full-length isoform 
of the gene is restricted to expression in the adult, and, when knocked down in a murine 
erythroid cell line or differentiated human primary adult CD34+ cells, causes an increase in fetal 
globin expression.  ChIP-seq analysis showed the protein binding directly to key DNase I 
hypersensitive sites in the LCR and other regions within the globin gene cluster itself [63,65].  
Following investigations demonstrated that differential regulation of BCL11A between mice and 
humans is major factor contributing to the divergent globin switching patterns observed between 
the two species [64].  As a critical repressor of fetal hemoglobin in the adult state, it was 
hypothesized that knockout of this gene in erythroid cells would sufficiently increase HbF levels 
to correct the hematologic defects associated with sickle cell disease.  This result was confirmed 
using an erythroid specific knockout system in a humanized mouse model of sickle cell disease 
[66].  However, despite the substantial strides in understanding the role of BCL11A and the 
BCL11A pathway in globin switching, there are still significant gaps in our knowledge of the 
mechanisms surrounding the protein’s function.  For example, the regulation of BCL11A itself in 
the erythroid lineage needs to be more clearly defined.  Naturally occurring human variations in 
transcription factors binding sites within the gene body have been shown to affect BCL11A 
expression, and therefore globin expression [67].  However, many of the upstream regulators of 
10 
 
BCL11A remain to be elucidated, including links to signals received from the external 
environment that can regulate globin expression [55].  Downstream of the regulation of BCL11A 
expression, further investigation is still needed to determine the exact mechanism of its 
regulation of the globin locus, which can help to further clinical efforts to intervene in the 
pathway [68].   
Some genes that interact with BCL11A have been determined, and they also contribute to 
the regulation of the globin genes.  SOX6 is a HMG-box-containing transcription factor that 
cooperates with BCL11A to repress γ-globin.  The factors co-occupy key sites in the LCR, 
proximal promoters, and other regions of the globin locus as well as physically interact.  These 
factors work together to modify the overall structure of the looping between the LCR and the 
proximal globin gene promoters, which in turn contributes to alterations in globin gene 
expression patterns [65].  Other factors that physically interact with BCL11A have been 
identified include TRIM28, NuRD complex members, MARTIN3, SWI/SNF complex members, 
and DNMT1.  However, the mechanism of action of these factors remains unclear as well as 
how, if at all, they affect the regulation of globin switching [63,68,69].            
Other factors such as EKLF [70,71], LDB1 [72,73], CTCF [74,75], MYB [76], and 
IKAROS [77,78] have been demonstrated to have or implicated in a role in the regulation of 
hemoglobin switching, in addition to many others [38,40,47,68,79].  The mechanisms of many of 
these factors and how they integrate into the mechanism of central factors, such as BCL11A, and 
the general globin regulation network remain extremely unclear.  It is also likely others factors 
that contribute to globin regulation and switching will continue to emerge as new techniques and 
models are used to investigate the system. 
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Current and Potential Models in the Study of globin Regulation  
Current models of globin switching 
A number of models are currently used to investigate the process of globin switching.  
The models vary in ease of use, techniques that can be applied to them, base line globin 
expression patterns and transcriptional milieu, normal behavior, validity of particular types of 
inferences, and relevance to clinical use in humans.  In combination, they offer a wide breath of 
options, though no one system is ideal to a particular experiment and certain combinations of 
features remain unfulfilled.       
Cell culture models include immortalized cell lines as well as primary erythroid 
progenitors that are differentiated in culture.  Immortalized cell lines such as the human 
erythroleukemia line K562 [80–82], the murine erythroleukemia line GM979 [83,84], and other 
murine erythroleukemia (MEL) lines [85] have been used extensively to study to globin gene 
expression and regulation.  These cell lines offer the ability to generate large amounts of material 
to perform screens, ChIP-seq experiments, protein mass spectrometry and other larger scale 
experiments.  They also afford the opportunity to utilize an isolated system, free from external 
influences outside of the cell type in a mammalian context, and a variety of globin expression 
profiles including mainly human γ-globin in K562 cells [81] and murine embryonic and adult 
globin in GM979 cells [83].  However, they do not accurately recapitulated any endogenous cell 
type and may have a number of pathways involved in any given process disrupted due to their 
immortalization and high number of passages.  Primary cells afford similar benefits as cell lines, 
but are more limited in number and ease of acquisition.  They also provide a system more closely 
resembling the endogenous state.  A particularly essential primary cell tool in the study of 
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hemoglobin switching are primary human CD34+ cells [86–89].  These cells can be derived from 
adult peripheral blood, cord blood, and fetal liver, and when differentiated express the 
appropriate globins for their stage, adult, a mixture, and fetal, respectively [90].  This provides a 
system where endogenous differences, as well as induced differences, can be studies in a human 
system, in a relatively large number of cells.              
Whole model organisms are also often used in the study of hemoglobin switching.  
Organisms such as frogs [91,92], salamanders [93,94], and mice [95–97] have been utilized for 
decades.  These models allow investigators to probe effects and changes that occur at the level of 
the whole organism, in the context of an environment with multiple cell types, and throughout 
the natural developmental process.  In many cases there are practical limitations to utilizing 
whole organisms for particular experimental designs, such as high throughput screens.  These 
whole organismal systems, while generally conserved with humans, may vary in key elements 
under investigation.  For example, the murine globin switching process, while in a conserved 
mammalian system, has significant differences when compared to humans [64,98].  However, 
efforts have been made to engineer systems with different combinations of attributes and 
advantages.  Mice transduced with genomic material from humans have been used extensively to 
study and discover key features of the cis-regulatory elements surrounds the globin loci 
[37,99,100].  Stable transgenic mice containing the entire human β-globin locus have been 
developed [52] and successfully studied [101], as well as disease state mice, such as sickle cell 
models [66,102,103].  These animals can be used to test alterations to human regulatory systems 
and disease states, but in the context of a whole organism, allowing for a more holistic 
understanding of the human system.               
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From the initial discovery of hemoglobin [20], the presence of multiple forms of 
hemoglobin in human blood [1,59], sickle cell disease [104], and thalassemia [105,106], 
studying humans directly has also provided substantial contributions to our understanding of 
hemoglobin and hemoglobin switching.  Specific mutations such as the Corfu mutation, a 
naturally occurring 7.2 kb deletion in the human β-globin locus, has helped to define a regulatory 
region that influences the expression of both the fetal γ-globin and adult β-globin.  The region 
was also later shown to contain an important BCL11A binding site, potentially explaining part of 
the regions function [68,107].   The ability to directly examine the role of mutations and 
polymorphisms continues to contribute to the field, such as through genome wide association 
studies [60–62].  These naturally occurring mutations play an essential role in helping to 
understand globin switching [68].         
The zebrafish as a model for hemoglobin switching 
The zebrafish model, while used extensively in hematology research [108], has been 
under utilized in the study of hemoglobin switching.  Between the embryo and adult systems of 
the zebrafish, it offers a unique combination of features that could help to advance our 
understanding of the process.  One of the most significant advantages of the zebrafish system is 
the ability to perform large scale screens on a whole organism.  The ability to generate a large 
number of optically clear, externally fertilized embryos quickly, and then easily assay temporal 
and spatial gene expression by in situ hybridization allows both chemical and knockdown 
screens to be performed in a high-throughput manner [109–112].  It is also possible, while in 
lower throughput manner, to utilize the adult zebrafish for analysis [113].  These features are 
critical to extend the examination of globin switching beyond previously identified factors, and 
14 
 
the ability to easily access and utilize animals at all stages of development is particularly 
essential. 
Despite these advantages, there are also a number of limitations to screening in the 
system.  When performing knockdown screens, the mRNAs of genes are typically individually 
targeted using morpholinos (GeneTools, Philomath, OR) designed using published, publically 
available genomic data.  However, due to imperfections in the zebrafish genome assembly, 
selection of well defined transcription start sites and splice sites, which are needed for 
morpholinos targeting, is not always possible.  In addition, the whole genome duplication that 
took place in the zebrafish evolutionary lineage [114] has resulted in multiple copies of genes 
only represented by a single copy in mammalian systems.  It is often not possible to determine 
prior to screening if the function of the mammalian protein is preserved in one, both, or neither 
of the zebrafish genes.  Lastly, not all designed morpholinos will effectively target and 
knockdown their intended transcript, creating a false negative rate of approximately 11% [110].  
Chemical screens are also limited by a number of factors.  A number of the chemicals tested will 
most likely have unknown or multiple molecular targets or cause developmental delays, which 
can complicate downstream analysis [112].  Even chemicals for which the target is defined in 
mammalian systems may have a less potent, off-target, or an otherwise substantially different 
effect in zebrafish due to the difference in protein sequence, metabolic processing, or 
bioavailability.  The permeability of the zebrafish chorion, which is not always removed prior to 
screening, also may alter the effects of certain chemicals in the library [115].  Finally, while 
there is substantial conservation of gene and pathway function between zebrafish and mammals, 
differences may exist that render some information gleaned from zebrafish studies incorrect in 
the mammalian system. 
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As hemoglobin switching is inherently a process of development, the ability to easily 
compare, contrast, and interrogate all stages is central to gaining a better understanding of the 
process.  The zebrafish offers easier access to, and therefore easier ability to manipulate, whole 
organisms from the single cell stage through adulthood on an accelerated time scale.  The ability 
to easily isolate peripheral blood from nearly all stages of development allows the direct study of 
these primary cells in relatively large numbers and all stages of interest.  However, due to their 
smaller sized compared to mice, tissue collection from individuals is limited, but can be 
compensated for with the use of additional animals. 
The zebrafish is a particularly advantageous model for studying hematology, including 
hemoglobin switching.  The similarity to the human hematopoietic system and its regulation 
[3,7,116] is crucial to making observations that are relevant to the human system quickly.  The 
availability of established genetic mutants that have hematological phenotypes [28,116–119] 
allows follow up work to better characterize genes, chemicals, pathways identified by 
experimenting with them in known hematological contexts (e.g. no primitive red cells).  In 
addition, red cells are expendable in zebrafish embryos and early larva, making the study of 
genes that significantly disrupt red cells in early development more tractable [108,120,121].  In 
conjunction with these mutants, there is also an extensive set of transgenic fish for the study of 
hematology, such as the GATA-1/GFP line [122], and additional lines can be readily developed 
[123].    
Current State of globin Research in the Zebrafish Model 
Globin expression throughout the development of the zebrafish  
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As noted earlier, red cells in the zebrafish are generated in both the primitive and 
definitive waves.  The primitive wave is born in the ICM [27], is the only circulating red cell 
population for the first 4 dpf [28], and is can be detected past 7 dpf [27].  Definitive red cells 
differentiate, through a series of steps, from hematopoietic stem cells and begin to contribute to 
circulation at around 3.5 dpf [27].  The initial onset of globin expression begins at approximately 
the 12 somite stage [30] from at least one of the two known globin loci [124].  From analysis of 
cDNA libraries generated from 54-56 hpf wild-type zebrafish embryos, six globin genes were 
identified and termed αe1, αe2, αe3, βe1, βe2, and βe3 [30], one of which, βe1, had previously been 
identified in a cDNA library generated from 3-35 hpf embryos [125].  By protein analysis at this 
stage, only three globin proteins were identified (αe1, αe3, and βe1), but expression of mRNA at 24 
hpf, 48 hpf, and 120 hpf was confirmed by in situ hybridization for αe1/αe2 (sequence similarly 
prohibited separation), αe3, βe1, and βe2, while βe3 expression was not examined at 120 hpf but 
confirmed at the 2 previous stages.  The expression of all identified embryonic globins was 
substantially reduced at 72 hpf for unknown, potentially technical, reasons [30].  However, the 
discovery effort here, cDNA library analysis at 54-56 hpf, is not comprehensive.  Additional 
globin genes with similar sequences could be expressed off of different genomic loci, some 
globin genes could be expressed in the embryo or larva outside of this narrow time window, and 
particular clones expressed at low levels could be overlooked using this method.  When genomic 
fragments in phage and bacterial artificial chromosomes were sequenced and annotated with the 
known globin sequences, it was discovered that the embryonic globin sequences were arranged 
in a tail-to-tail fashion and linked with known adult globin sequences.  This demonstrated that, 
while there are two zebrafish globin loci, they are not arranged in a similar manner to the 
mammalian loci: (1) they are not segregated into α- and β-globin loci, and (2) they are not 
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organized in the same direction in the order to expression.  The results are consistent with other 
known fish species and the expected evolution of the globin loci [33,34,126].  However, these 
methods are limited in fully characterizing and completely annotating the two known zebrafish 
globin loci.               
Globin expression in the adult zebrafish has also been analyzed.  Utilizing cDNA 
libraries generated from adult peripheral red cell, three globins were identified and termed αa1, 
βa1, and βa2.  At the protein level, HPLC identified five expressed globin genes, those predicted 
to be transcribed from the identified cDNAs, αa1, βa1, and βa2, and the newly termed αa2 and αe3.  
Work identifying the genomic location of these genes demonstrated a head-to-head ordination of 
an α- and β-globin gene, demonstrating a non-mammalian system of organization [32].  The 
discrepancy between the number of globin genes expressed by analysis of the cDNA libraries 
and the protein products could be the results of differences between zebrafish, limitations of 
cDNA libraries, post-transcriptional modifications made to the globins, changes in globin 
expression over time (i.e. the cDNA for some or all of the proteins observed were previously 
transcribed and have been degraded), or technical issues resulted in aberrant identification of 
additional globin proteins (e.g. some of the proteins identified represent other red cell proteins).  
Taken together, these observations demonstrate that the zebrafish has at least one globin switch 
between an embryonic stage, defined by the expression of six globins and occurring at least 
between 54-56 hpf, and an adult stage, defined by the expression of between two and five 
globins [30,32].   
Later work expanded this analysis by analyzing globin expression at 24 different 
developmental stages between the one-cell stages and sexual maturity at 54 dpf using RT-PCR 
[127].  The globins were grouped into five categories, embryonic α and β, adult α and β, and a 
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newly identified embryonic α-globin termed hbαX, limiting the analysis in describing the 
fluctuations between the distinct α- and β-globins.  HbαX was identified by analysis of zebrafish 
genomic assemblies and comparing sequence homology to other identified globins within and 
from outside the species.  Its embryonic nature was determined by the timing of expression (see 
below).  Analysis of one-cell stage embryos showed high levels of expression of all five globin 
categories as compared to the next developmental stage examined (4 hpf), implying maternal 
contribution of a wide variety of globin mRNAs [127].  Zygotic embryonic globin expression 
then begins to be detected around 12-18 hpf [127], consistent with previous work [30], and peaks 
at approximately 72 hpf [127].  Expression of all three embryonic globin groups continued 
through the next 14 developmental stages and into adulthood (54 dpf).  A significant increase in 
the expression of the adult globin groups was first detected at 14 dpf, with continued expression 
through the remaining 5 developmental stages tested and into the adult stage [127].  These results 
do not agree with earlier observations where only adult globin mRNAs are detected in the adult 
stage [32], but, if accurate, could potentially explain some of the inconsistencies between the 
number of globins observed in the mRNA and protein analyses.  Within both the embryonic and 
adult globin expression ranges, the expressions levels also fluctuate substantially. The expression 
of both the adult α- and β-globin increase around 3-4 dpf before decreasing again at 5 dpf, and 
the expression of all three embryonic globin groups significantly decrease between 7-9 dpf 
before recovering to previous levels [127].  These fluctuations, in contrast to observing a defined 
period of expression proceeded by a period of increase and followed by a period of decrease, 
may indicate that different globins within the groups are not adhering to the same expression 
pattern.  This indicates that grouping the zebrafish globin genes into five categories may not 
provide sufficient resolution to accurately assess the pattern of globin switching in the zebrafish.           
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Known regulators of globin expression in the zebrafish    
While the globin genomic loci and normal developmental switching pattern remain 
incompletely characterized, environmental and transacting factors that regulate the process have 
begun to be identified.  One of the environmental factors that triggers a shift in the expression of 
globin genes is hypoxia.  As globin genes are integrally involved in the oxygen state of an 
organism, it is perhaps not unexpected that one of the physiological responses to a reduced 
oxygen state is to modulate globin expression.  When exposed to hypoxic conditions, zebrafish 
globin mRNA, α and β, expression decreases [128].  This is in contrast to observations in 
mammals and other fish species, such as medaka [128,129].  While it is possible that this may be 
a response unique to zebrafish, it is also possible that the limited globin genes observed, an 
unknown collection of globins grouped and assessed only as α and β, do not reflect total globin 
levels.  In humans, hypoxia can induce higher levels of fetal globin [130], so it is possible a 
similar mechanism is increasing the level of globin genes that were not assessed, such as larval 
globins, in addition to decreasing the levels of the globins that were tracked.  Some of the 
downstream factors of this environmental trigger of fetal globin induction are known, such as 
HIF-1 [131], but the mechanisms of action of these factors in zebrafish hemoglobin switching 
are largely undetermined.   
As mentioned above, the KLF genes play a critical role in globin expression in mammals 
[70,71], and the family has also been implicated in the regulation of globin expression in the 
zebrafish.  Klf4 has been shown to regulate globin expression only in primitive erythrocytes, 
which express embryonic globins, and not definitive erythrocytes, which express adult.  
Knockdown experiments demonstrate that the gene is essential for embryonic globin production, 
but dispensable for adult [132].  Similarly, other zebrafish klf family members have been shown 
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to have distinct roles in embryonic globin expressing primitive cells and adult globin expressing 
definitive cells [133,134].  In addition, some regulatory mechanisms governing differential 
globin expression likely act though klf family members.   MiR-144 has been shown to negatively 
regulate embryonic α-globin, but not β-globin, though its regulation of klfd, which binds 
exclusively to the promoter of αe1 and not βe1 [135].  Despite the high levels of expression, layers 
of regulatory controls, and other cellular resources dedicated to the production of primitive 
zebrafish red cells, they, as mentioned earlier, are not essential to life in the developing embryo 
for approximately 7 days [108,120,121].     
 Critical Pathways that Regulate Development in Zebrafish and Mammals 
The role of the Wnt pathway in development 
The Wnt pathway is one of the most critical, diverse, and complex pathways regulating 
development and adult homeostasis.  There are three branches of the pathway: (1) the canonical 
pathway, which is converges on β-catenin, (2) the non-canonical pathway, and (3) the Wnt/Ca2+ 
pathway, both of which are β-catenin independent [136].  The pathway has known roles in early 
embryonic patterning and axis formation, cell fate decisions, organ development, appendage 
patterning, and disease states, namely cancers [136–141].  The Wnt pathway has been shown to 
play a particularly key role in hematopoiesis, playing a role in the self-renewal of HSCs, 
proliferation, the cell fate decisions within the lineage, and during the differentiation of a number 
of cell types [140,142–144].  The Wnt pathway is a highly conserved pathway from C. elegans 
to humans, including zebrafish [136,145].  Briefly, in canonical Wnt signaling, the central factor 
is β-catenin.  In the inactive state, it is degraded by the destruction complex (composed of AXIN, 
APC, GSK3β, and others) in the cytoplasm, preventing it from entering the nucleus.  In the 
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nucleus, the protein Groucho binds to TCF family proteins and modulates gene expression.  In 
the active state, Wnt ligand stimulates the receptor complex of Frizzled and LRP 5/6 proteins, 
which triggers the sequestration of critical destruction complex proteins.  In the absence of the 
destruction complex, β-catenin accumulates, enters the nucleus, binds to TCF family members 
and modulates gene transcription [136].  Despite the numerous and critical role the diverse arms 
of the Wnt pathway play in development and hematopoiesis, there is no known direct role of the 
pathway in globin switching.            
The role of the thyroid hormone receptor pathway in development 
The nuclear hormone receptor pathway is another critical and well conserved 
developmental and homeostasis pathway.  It is composed of over 30 individual receptors in 
humans, only a fraction of which have identified endogenous ligands.  Together, they are known 
to play roles in embryonic development, metabolism, cell identity, and diseases related to these 
functions such as cancer and obesity.  In addition to the receptors and ligands themselves, the 
nuclear hormone receptor family contains a number of coregulators and heterodimeric receptor 
partners.  The coregulators are grouped into the corepressors, such as NCOR1 and NCOR2, and 
coactivators, such as NCOA1 and NCOA2, and the RXR proteins are utilized by a number of the 
other nuclear hormone receptors as heterodimeric partners, only binding to DNA with an RXR 
partner [146].  The thyroid hormone receptor pathway is a member of this superfamily that plays 
a particularly central role in early development and metabolism, as well as diseases such as 
diabetes [147,148].  The ligand for the thyroid hormone receptors (TRs) is thyroid hormone, 
3,3',5-triiodo-L-thyronine (T3), which is generated from the partially active precursor L-
thyroxine (T4) and processed to T3 in mammals by either of two deiodinase enzymes, D1 or D2.  
T4 can also be inactivated to reverse T3, and both T3 and reverse T3 can be degraded further to 
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the inactive T2.  These processing steps allow for finer control of thyroid hormone activity as the 
correct balance of both precursor hormone and deiodinase enzymes must be preset to generate 
T3 [149].  Under normal cellular conditions in which a TR is expressed, the receptor is bound to 
thyroid hormone response elements (TREs) with an RXR partner.  The presence or absence of 
ligand regulates which other proteins are bound in the complex.  In the presence of a saturating 
amount of ligand, they are bound to a coactivator, and in the absence of ligand to a corepressor, 
while an intermediate amount results in a dynamic equilibrium between the two states.  While 
the nomenclature may indicate that gene transcription is activated in one state and repressed in 
another, the effect is not correlated to the coregulator or ligand state, but whether the TRE is a 
“positive,” active in the present of ligand, or “negative,” active in the absence of ligand, target 
[150].  However, emerging evidence also suggests that variations in the TRE sequence can also 
determine whether the TR needs an RXR partner or coregulator to modulate gene expression 
[151].  In humans and mice, there are two distinct TR receptors, TRα and TRβ, which have 
overlapping but separate roles and can be expressed in different tissues at different times.  In 
zebrafish, there are three receptors, thraa, thrab, and thrb [152].  The thyroid hormone regulates, 
and is essential to, metamorphosis in frogs and other amphibians [153,154] as well as teleost, 
including zebrafish [155], and T3 and T4 levels are modulated accordingly [156].  In frogs, a 
direct link between the thyroid hormone receptor pathway and globin switching has been 
established as an element of metamorphosis [157,158].  While mammals do not undergo classic 
metamorphosis as amphibians and teleosts do, thyroid hormone has been linked to like 
postembryonic developmental changes reminiscent of metamorphosis [159].  The two thyroid 
hormone receptors are known to have distinct functions in mammals from the study of a large 
number of mouse mutants, and no known role in globin switching [160–162], but hematopoietic 
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and erythroid defects have been identified, mostly associated with TRα [163,164].  The thyroid 
hormone receptor pathway is also known to interact with other essential developmental pathway, 
such as the Wnt pathway [165–168], but this intersection has not been observed to play a role in 
hemoglobin switching.   
Thesis Review 
This thesis fully characterizes the zebrafish as a model for hemoglobin switching and 
successfully utilizes it to identify and characterize pathways involved in globin gene regulation 
in the zebrafish and mammals, which could be modulated to treat hemoglobinopathies.  By fully 
annotating both globin gene loci and establishing the normal globin expression pattern for each 
globin from the onset of expression into adulthood, disruptions and modulations to this pattern 
could be observed.  Through this process, two globin switches were identified, analogous to the 
pattern observed in humans.  In addition, the mapping of DNase I hypersensitive regions and the 
binding of the erythroid master regulator Gata1 were used to locate the major locus LCR.  This 
region was later found to enhance robust, erythroid-specific reporter expression in a transgenic 
zebrafish line.   
Through morpholino and chemical screens, the Wnt and thyroid hormone receptor 
pathways were identified as regulators of the normal globin switching process as they disrupted 
the baseline expression of the adult globin gene αa1 in the embryo.  These pathways are shown to 
cooperate in the regulation of globin genes through co-treatments with both morpholinos and 
small molecules.  Further analysis demonstrates that the thyroid hormone receptor pathway 
upregulates both adult globin mRNA and protein, with, at the doses used, little effect on other 
aspects of red cell and general development.  Investigating this pathway in the adult shows that 
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the pathway is not only used in the establishment of the adult states, but also in its maintenance 
as the treatment of adult with a thyroid hormone receptor antagonist induces embryonic globin 
mRNA and protein.  The function of this pathway is conserved in the mammalian system, as 
demonstrated through K562 and human CD34+ cell culture.  ChIP-seq experiment in both the 
zebrafish and human systems show that this pathway works directly on globin loci to modulate 
gene expression.  By establishing the zebrafish as a model of hemoglobin switching and 
identifying and characterizing two pathways that regulate globin expression, additional avenues 
for research into the regulation of globin switching and potential therapies for 
hemoglobinopathies have been opened. 
 
 
  
 
 
 
 
 
 
 
Chapter 2 
 
Zebrafish globin switching occurs in two developmental stages and is controlled by the LCR 
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Abstract 
Globin gene switching is a complex, highly regulated process allowing expression of 
distinct globin genes at specific developmental stages. Here, for the first time, we have 
characterized all of the zebrafish globins based on the completed genomic sequence.  Two 
distinct chromosomal loci, termed major (chromosome 3) and minor (chromosome 12), harbor 
the globin genes containing α/β pairs in a 5’-3’ to 3’-5’ orientation. Both these loci share synteny 
with the mammalian α-globin locus. Zebrafish globin expression was assayed during 
development and demonstrated two globin switches, similar to human development.  A 
conserved regulatory element, the locus control region (LCR), was revealed by analyzing DNase 
I hypersensitive sites, H3K4 trimethylation marks and GATA1 binding sites.  Surprisingly, the 
position of these sites with relation to the globin genes is evolutionarily conserved, despite a lack 
of overall sequence conservation.  Motifs within the zebrafish LCR include CACCC, GATA, and 
NFE2 sites, suggesting functional interactions with known transcription factors but not the same 
LCR architecture.  Functional homology to the mammalian α-LCR MCS-R2 region was 
confirmed by robust and specific reporter expression in erythrocytes of transgenic zebrafish.  Our 
studies provide a comprehensive characterization of the zebrafish globin loci and clarify the 
regulation of globin switching.    
Introduction 
In organisms dependent on functional hemoglobin for oxygen transport, regulation of its 
production is vital, and misregulation can have catastrophic effects.  An elaborate regulatory 
mechanism has evolved to govern globin production and globin switching, the process by which 
precise changes occur in α- and β-globin production in an organism throughout development.  
globin switching occurs in many species across ontogeny, including humans and other mammals, 
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and relies on both highly conserved and unique cis- and trans-regulatory elements 
[33,38,40,43,170,171].  A driving force of globin switching at the organismal level is a series of 
waves of hematopoiesis defined by the production of erythrocyte precursors in different 
anatomical locations [4] “Maturational” globin switching, or the switch in globin production of 
an individual cell as it matures through erythropoiesis, also plays a critical role in defining the 
globin expression signature of the organism as a whole [26]. 
Genetic disorders in which this process is disrupted, either through the mutation of 
regulatory regions or globin coding sequences themselves, are collectively known as 
hemoglobinopathies [38,98,172].  These disorders include the thalassemias and sickle cell 
disease [173–175], which remain a major health concern worldwide [176,177].  The molecular 
complexity and clinical relevance of globin switching has made it an area of intense basic and 
clinical research; sickle cell anemia was the first disease for which the molecular basis was 
described [176,178,179].   
Fundamental mechanisms of gene regulation [96,180], particularly those of long-range 
regulatory elements, were initially discovered and studied in this system [37,170].  Clinical 
observations, including that higher levels of persistent fetal Globin in sickle cell patients 
ameliorates symptoms, have focused further research towards influencing this globin switch as a 
treatment option [176,181].  Despite these substantial efforts and even breakthroughs, aspects of 
the mechanism of globin regulation remain unclear and a cure for the hemoglobinopathies 
elusive [176].   
Conserved long-range regulatory elements play a critical role in globin expression and 
switching.  These enhancer regions are typically, as in the globin locus, characterized by DNase I 
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hypersensitive sites (HS) annotated by their position (in kilobases) upstream of the globin coding 
sequences [170].  The DNase I hypersensitive site ~40kb upstream (HS-40) of the α-globin locus 
in humans has been demonstrated to be essential for proper globin expression, with other 
hypersensitive sites spanning as much as 150kb playing roles in the process [35,38,182].  The 
conservation in coding, noncoding regulatory and overall synteny of the globin loci can be traced 
to the ancestral globin locus present in early jawed vertebrates, which contained both α- and β-
globins.  The locus has diverged over time and segregated into separate α and β loci after the 
divergence of amphibians [33,34], but essential functions have been shown to be conserved 
[33,34,41–43,45,183].  Analysis of this conservation in noncoding regions reveals the presence 
of multispecies conserved sequences (MCS), which when aligned with DNase I HS often define 
a functional regulatory sequence.  This has allowed for the definition of homologous regions in 
different species, as well as guided identification of new regulatory elements [40].     
The zebrafish, Danio rerio has already been established as an important model to study 
developmental hematopoiesis [184,185].  Advantages include high fecundity, accelerated 
development, external fertilization, and transparent embryos, allowing for the real-time in vivo 
visualization.  Importantly, the embryos do not require hemoglobin or red blood cells through at 
least the first 15 days of development [186], allowing for detailed loss-of-function studies not 
possible in other organisms.  Similarly, these features allow for large-scale chemical screening 
not feasible in mammals [187].  Of particular interest is the ability to generate transgenic 
organisms quickly and perform whole-organism, live fluorescent imaging.   
The adult [32] and embryonic [30] globins in the zebrafish have been characterized by 
identifying some of the adult and embryonic globins, both α and β, within both globin loci.    
Here, the first detailed elucidation of the globin expression pattern changes allowed the 
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observation and characterization of embryonic-to-larval and larval-to-adult globin switches 
during development, consistent with humans [98].  A conserved regulatory element has also been 
revealed by DNase I hypersensitivity mapping and GATA1 binding data, which we show 
functionally drives robust and specific expression in red blood cells, validating these techniques 
for identifying regulatory regions.  Additional putative enhancer elements in the major locus and 
minor locus were also observed and warrant further investigation.  These data fully characterize 
the zebrafish as a model of globin switching by defining the coding regions, synteny, genomic 
structure, regulatory regions and expression pattern of the zebrafish globin gene loci as well as 
demonstrate the level of conservation at both the molecular and functional level between 
zebrafish and humans.    
Materials and Methods 
Zebrafish maintenance 
Zebrafish were staged, raised, and maintained as described [188,189].  All zebrafish 
experiments and procedures were performed as approved by the Children’s Hospital Boston 
institutional Animal Care and Use Committee.  
RNA isolation and cDNA preparation 
Pools of fifty zebrafish from the 18 somite stage (ss) through 32 days postfertilization 
(dpf) were collected and homogenized in Trizol reagent (Invitrogen, Carlsbad, CA). Small pools 
of adult fish were also homogenized in Trizol, and total RNA was isolated using the 
manufacturer’s protocol and further purified with the RNeasy kit (Qiagen, Germantown, MD). 
Subsequently, 1 µg of total RNA was used to generate cDNA using the Superscript III system 
(Invitrogen).   
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Quantitative real-time PCR 
Quantitative real-time PCR was performed on an iCycler IQ5 Real-Time PCR detection 
system (Bio-Rad, Hercules, CA) using SYBR Green Supermix (Bio-Rad), and fold change was 
determined using the Gene Expression Analysis for iCycler iQ Macro (Bio-Rad).   
Synthesized cDNA was diluted 1:2, and 1 µl was used in a 20 µl SYBR green PCR 
reaction (SYBR Green Supermix, Bio-Rad) containing 200 nM of forward and reverse primers.  
Beacon Designer primer software was used to design qPCR primers to unique zebrafish globin 
genes.  Careful attention was made to avoid haplotype-specific regions, and optimized primer 
pairs are shown in Table 2-1.  The products were amplified using a two-step program cycling at 
95°C for 10 sec and 57°C for 30 sec followed by melting curve analysis.  Gene expression levels 
were normalized to an erythrocyte-specific membrane gene, band3, and PCR efficiency curves 
were done for all primer pair sets to assign absolute values to each gene.  Data were plotted in 
two separate groups of α- and β-globins as a percentage of each globin during each time point 
during the developmental profile. 
Generation of zebrafish transgenics 
The LCR and α/β adult globin 2 (α/βa2) bidirectional promoter were, respectively, 
isolated by restriction enzyme and PCR amplified and cloned into pEGFP-1 vector to create the 
α/βa2-GFP construct.  Additional LCR fragments were amplified by PCR and assembled into 
expression vectors containing transposon elements using the Gateway system (Invitrogen).   
A 1.2 kb fragment of the α/β adult globin 2 (α/βa2) bidirectional promoter was PCR 
amplified from the zC113F11 bacterial artificial chromosome (BAC) clone and ligated into the  
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Table 2-1: Sequences of primers used in quantitative real-time PCR. 
Gene PCR primer Sequence 5’ 3’ 
αe1a/b/c forward CCAGGATGTTGATTGTCTAC 
αe1a/b/c reverse  CAGTCTTGCCGTGTTTC 
αe3 forward CCTAAGCCCCAACTCTC 
αe3 reverse CTCCCTTCAGGTCATCC 
αe4 forward GTGGCGGAAGAAATTGG 
αe4 reverse ATGGAACCTGCTAAGTGG 
αe5  forward CCTCAGACCAAGACCTAC 
αe5  reverse TCAGACAGAGCCAAAGC 
αa1a/b  forward CAAGGCTGTTGTTAAGGC 
αa1a/b  reverse ATTCTGGCGAGGGCTTC 
αa2 forward GCGAATGCTTACTGTCTAC 
αa2 reverse TGTCACGAGGATGTTATGG 
βe1a/b/c  forward CTTGACCATCGTTGTTG 
βe1a/b/c  reverse GATGAATTTCTGGAAAGC 
βe2  forward ACTATGAGGAGGCTGGAC 
βe2  reverse CGGCGTAGGTGTTCTTG 
βe3  forward ATGCTTGGTCGTCTATCC 
βe3  reverse ATGATTGCCTCTGTGTTG 
βa1a/b forward ATATTTCGCCACATTCG 
βa1a/b  reverse GCATAGGTGTTCTTGA 
βa2 forward ATTGCGAGTGTCTGGAG 
βa2 reverse CCGTGTTCTGAAACTTTGG 
slc4a1 forward AGTTAGAGCCTGTTGTATCC 
slc4a1 reverse  TCCATCACCACCGAATCC 
 
33 
 
pEGFP-1 vector to create the α/βa2-GFP construct.  A restriction fragment cloning approach was 
undertaken to excise the intron containing the conserved LCR. 
The zC113F11 BAC was digested with Kpn I/ Sma I to liberate a 6.2 kb fragment 
containing intron 5 and the adjacent exons.  This fragment was ligated upstream of the α/βa2 
promoter to complete the α-LCR-α/βa2-GFP transgenic construct.  This construct was liberated 
from the pEGFP-1 vector by digestion with Kpn I and Nae I and gel purified using the QIAEX II 
gel extraction kit (Qiagen).    GFP positive LCR-α/βa2-GFP were raised and outcrossed to 
identify germline founders. 
Additional reporter constructs were generated by PCR amplifying the desired portions of 
the LCR-α/βa2-GFP transgenic construct into the Gateway entry pENTR 5’-TOPO vector 
(Invitrogen), into which the α/βa2 promoter was sub-cloned using the restriction enzyme BamHI 
downstream of the LCR fragment in the cases where it is included in the final expression vector.  
The appropriate 5’ vector, vector #383, vector # 302 and vector #394 (Kwan et al., 2007) were 
assembled into the final expression vectors DNaseIpeak-LCR-α/βa2-GFP and GATA1peak-LCR-
α/βa2-GFP using LR Clonase II Plus (Invitrogen).  The expression constructs containing the 
enhancer elements and the mouse minimal promoter were similarly assembled utilizing the 
Gateway system (Invitrogen).  The respective enhancer fragments were cloned into pENTR 5’-
TOPO and assembled using a Gateway LR reaction with vector #302, vector #394 and the 
middle entry vector pME-MinPro-GFP to form the expression vectors DNaseIpeak-LCR-
MinPro-GFP and Gata1peak-LCR-MinPro-GFP.  To assemble the LCR without the DNase I 
peak, LCRP1/P2-MinPro-GFP, the fragment of the LCR 5’ of the DNase I peak was amplified 
by PCR and cloned into pENTR 5’-TOPO (Invitrogen).  The fragment of the LCR 3’ of the 
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DNase I peak was amplified by PCR and cloned into pENTR 5’-TOPO (Invitrogen).  The 5’ 
fragment was then liberated by digest with BglII and BssHII (added to the primer sequences) and 
cloned, in the correct orientation, into the vector containing the 3’ LCR fragment.  This 5’ entry 
vector was then assembled using a Gateway LR reaction with vector #302, vector #394 and 
pME-MinPro-GFP to form the expression vector LCRP1/P2-MinPro-GFP.   
The middle entry vector pME-MinPro-GFP was constructed by PCR amplifying and 
inserting the minimal promoter from the mouse β-globin gene, previously used for enhancer 
screening in zebrafish (Woolfe et al., 2005), upstream of GFP (into the NcoI site of vector #383 
[123]; NcoI sites added in primers: β-globin forward primer, 
GGCACCATGGCCAATCTGCTCAGAGAGGACA; β-globin reverse primer, 
GGCACCATGGGATGTCTGTTTCTGAGGTTGC). 
All injections were carried out at the one cell stage.  For the pEGFP-1 based vectors the 
linearized LCR-α/βa2-GFP construct DNA or α/βa2-GFP control DNA were injected at 100 
ng/µl.  Injections of the vectors assembled using the Gateway system were injected at 25 ng/ul in 
combination with Tol2 mRNA (15 ng/ul).  The transiently injected embryos were observed at 24 
hpf using a fluorescent microscope. 
FACS Analysis of zebrafish peripheral blood  
Zebrafish peripheral blood was isolated from deeply anesthetized adult α-LCR-α/βa2-
eGFP zebrafish as previously described [190], with the following modifications. Peripheral 
blood cells were placed into 200-300 uL of 0.9% PBS containing 5% fetal calf serum and 100 
U/mL heparin, then filtered through a 40 μm nylon mesh to ensure a single cell suspension. 
Propidium iodide at 1 ug/mL (Sigma) was added as a marker to exclude dead cells and debris. 
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Fluorescence activated cell sorter (FACS) analysis was performed based on PI exclusion, 
forward scatter, side scatter, and GFP fluorescence using a FACS Vantage flow cytometer 
(Becton Dickinson, San Jose, CA). FACS data were analyzed using FloJo software. 
DNase I hypersensitivity assay 
Zebrafish peripheral blood was collected by cardiac puncture in anesthetized adult 
zebrafish.  As the mature erythrocytes in lower vertebrates retain their nuclei, we are able to 
isolate erythrocyte nuclei from peripheral blood.  Zebrafish liver tissues were dissected from 
anesthetized adult fish and cell suspensions were made using a glass tissue homogenizer in 1X 
PBS.  DNase I hypersensitivity assays of both erythrocytes and liver cells were carried out as 
previously described (Sabo et al., 2006).   Bowtie [191] was used to map DNase I sequence reads 
onto Zv9 and formatted into BAM files. MACS [192] was used to compute peaks and create 
browser tracks. 
Briefly,  the cells were treated with 0.025% Igepal in Buffer A (15 mM NaCl, 60 mM 
KCl, 1 mM EDTA, 0.5 mM EGTA, 0.5 mM Spermidine) for 8 minutes.  The released nuclei 
were pelleted and incubated for 3 minutes at 37°C in DNase buffer (13.5mM Tris-Cl pH8.0, 88.5 
mM NaCl, 54 mM KCl, 0.9 mM EDTA, 0.45 mM EGTA, 0.45 mM Spermidine, 6 mM CaCl2) 
plus 0, 40, 60, 80 or120 units/ml of DNase I (Sigma Aldrich). The reaction was stopped by the 
addition of an equivalent volume of Stop Buffer (50mM Tris-Cl pH 8.0, 100 mM NaCl, 0.10 
%SDS, 100 mM EDTA) and incubated for 1 hr with 1100 units/ml Proteinase K.  Small DNase I 
fragments from the 120 unit DNase I treatement were enriched using a sucrose gradient as 
previously described [193].  These ends were then labeled and amplified for Solexa sequencing 
as previously described [194].  Bowtie [191] was used to map DNase I sequence reads onto Zv9 
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and formatted into BAM files. MACS [192] was used to compute peaks and create browser 
tracks with the following input parameters: gsize = 15000000000; bandwidth = 50; and p-value = 
1e-09. 
ChIP-seq of zebrafish red cells 
ChIP was performed [195], the sample sequenced and bioinformatic analysis performed 
[192] as previously described.  Briefly, red cells from 10 adult zebrafish were isolated for each 
ChIP-seq reaction, cross-linked, prepared with the Illumina/Solexa Genomic DNA kit (Illumina- 
IP-102-1001), sequenced and analyzed using Model-based Analysis of ChIP-seq (MACS) [192].   
Red cells from 10 adult zebrafish were isolated for each ChIP-seq reaction. The cells 
were isolated by puncturing the zebrafish heart with a heparinized tip and were transferred to a 
tube of 0.9% PBS, 5% fetal bovine serum, and 0.3U-1U heparin/ml. ChIP was performed as 
described in Lee et al.[195]. Cells were crosslinked with the addition of 1/10 of 11% 
formaldehyde diluted in Formaldehyde solution (50 mM HEPES-KOH, pH 7.5, 100 mM NaCl, 1 
mM EDTA, 0.5 mM EGTA and 11% formaldehyde) for 5 min at room temperature. 1/20 of 
2.5M Glycine was added to quench the formaldehyde and the cells were washed twice with ice 
cold PBS. Cells were either flash frozen in liquid nitrogen and kept at -80°C or processed 
immediately with the addition of 10 ml of lysis solution 1 (50 mM HEPES-KOH, pH 7.5, 140 
mM NaCl, 1 mM EDTA, 10% glycerol, 0.5% NP-40, 0.25% Triton X-100, 1× protease 
inhibitors) and incubation for 10min at 4°C. The cell lysate was centrifuged for 5min at 4°C at 
1350g and the pellet was resuspended in 10ml of lysis solution 2 (10 mM Tris-HCl, pH 8.0, 200 
mM NaCl, 1 mMEDTA, 0.5 mM EGTA, 1× protease inhibitors) and incubated for 10 min at 
room temperature. The cells were pelleted for 5min at 1350g at 4°C and then resuspended in 1ml 
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of Lysis buffer 3/Sonication buffer (10 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.5 
mM EGTA, 0.1% Na-Deoxycholate, 0.5% N-lauroylsarcosine, 1× protease inhibitors). The 
lysate was sonicated in a Bioruptor sonicator for 25 cycles of 30sec with 59 sec intermission 
between each cycle. The lysate was centrifuged for 10 min at 18.000g at 4°C. The supernatant 
was transferred to a new tube and 10% Triton X was added.  The lysate was added to 50 of 
Dynal beads that were crosslinked to GATA1 (Anaspec 55507) or H3K4me3 (Millipore 07473) 
antibody. 50 µl of lysate was kept for whole cell extracts. To crosslink the antibodies to the 
beads, 50 µl of beads were washed twice with PBS with 0.5% BSA and then 250µl of 
PBS/0.5%BSA together with 5µg of antibody was added to the beads. The beads were left to 
rotate for at least 6hrs to overnight at 4°C. After the incubation the beads were washed twice 
with PBS/BSA 0.5% and were ready to use. 
After the addition of the cell lysate to the beads the tubes were left to rotate at 4°C 
overnight. Next day the beads were washed for 4 min each time in the following consecutive 
solutions. Beads are washed 1X with wash buffer 1 (20mM Tris-HCl pH8, 150 mM NaCl, 2mM 
EDTA, 0.1% SDS, 1%Triton X-100), 1X with wash buffer 2 (20mM Tris-HCl pH8, 500mM 
NaCl, 2mM EDTA, 0.1% SDS, 1%Triton X-100), 1X with wash buffer 3 (10mM Tris-HCl pH8, 
250nM LiCl, 2mM EDTA, 1% NP40) and 1X with TE. All washes are performed at 4°C.  The 
chromatin was eluted from the beads with the addition of 200μl elution buffer (50 mM Tris-Hcl, 
pH 8.0, 10 mM EDTA and 1% SDS) by heating at 65°C for 30 minutes in a shaking heat block. 
The eluted chromatin was transferred to a new tube and the crosslinking was reversed by heating 
at 65°C for 6hrs to overnight.  The whole cell extracts were also reverse crosslinked by the same 
procedure after the addition of 150µl of elution buffer. 
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After the reversal of crosslinking RNAse was added to the lysate at a final concentration 
of 0.2mg/ml for 2hrs at 37°C, followed by the addition of proteinase K at a final concentration of 
0.2µg/ml for 2hrs at 55°C. The DNA was recovered by Phenol/Chloroform/Isamylic alcohol 
precipitation and resuspended in 30µl of H2O for the ChIP and 150µl for the whole cell extracts. 
ChIP-seq sample preparation [196]  
The samples were prepared with the Illumina/Solexa Genomic DNA kit (Illumina- IP-
102-1001) according to the manufacturer’s instructions. Briefly 200ng of Input DNA and 50ng 
of ChIP DNA are used. The first step was to turn the DNA overhangs into phosphorylated blunt 
ends. The sample was then purified with a Qiagen PCR purification kit. The second step of the 
library preparation was the addition of a single A in the 3’ end to allow for directional ligation. 
Samples were purified again with the Qiagen MimElute kit. Next, Illumina adapter 
oligonucleotides (1/100 dilution) were added to the samples, followed by purification of the 
samples with the Qiagen PCR purification kit. The samples were amplified by PCR (limited 
amplification to 18 cycles) that added additional linker sequence to the fragments to prepare 
them for annealing to binding sites in the Genome Analyzer flow-cell. The amplified samples 
were then separated on a 2% agarose gel and products between 150-350 bp were selected and 
extracted from the gel (the products include fragments of 50-250 bp plus approximately 100 bp 
of primer sequence).  All protocols for Illumina/Solexa sequence preparation, sequencing and 
quality control are provided by Illumina (http://www.illumina.com/pages.ilmn?ID=203).  
Polony generation and sequencing 
The DNA library (2-4 pM) was applied to the flow-cell (8 samples per flow-cell) using 
the Cluster Station device from Illumina. The concentration of library applied to the flow-cell 
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was calibrated such that polonies generated in the bridge amplification step originate from single 
strands of DNA. Multiple rounds of amplification reagents were flowed across the cell in the 
bridge amplification step to generate polonies of approximately 1,000 strands in 1 μm diameter 
spots. Double stranded polonies were visually checked for density and morphology by staining 
with a 1:5000 dilution of SYBR Green I (Invitrogen) and visualizing with a microscope under 
fluorescent illumination. Validated flow-cells were stored at 4°C until sequencing. Flow-cells 
were removed from storage and subjected to linearization and annealing of sequencing primer on 
the Cluster Station. Primed flow-cells were loaded into the Illumina Genome Analyzer 1G. After 
the first base was incorporated in the Sequencing by-Synthesis reaction the process was paused 
for a quality control checkpoint. A small section of each lane was imaged and the average 
intensity value for all four bases was compared to minimum thresholds. Flow-cells with low first 
base intensities were reprimed and if signal was not recovered the flow-cell was aborted. Flow-
cells with signal intensities meeting the minimum thresholds were resumed and sequenced for 26 
cycles. 
Bioinformatics analysis of ChIP-seq data 
Samples were sequenced and mapped to ZV9 at the Whitehead Institute Genome 
Technology Core. Peaks were detected for nominally 36 bp short reads passing Eland quality 
control using Model-based Analysis of ChIP-seq (MACS) [192] with a bandwidth of 50, mfold 
of 15, and p-value of 1e-09. The resulting WIG files from MACS were used for visualizing the 
results. 
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In situ hybridization 
The whole-mount in situ hybridization protocol was carried out as previously described 
[197] using antisense probes amplified from digested plasmids.      
Accession numbers 
The Dnase I and ChIP-seq data discussed in this publication have been deposited in 
NCBI's Gene Expression Omnibus [198] and are accessible through GEO Series accession 
number GSE35895 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35895). 
Results 
Analysis of the genomic regions of the globin gene loci 
The genes encoding the zebrafish globins reside on two separate chromosomes. 
Chromosome 3 contains the major globin locus with 13 globin genes and chromosome 12 houses 
the minor globin locus with four globin genes (Figure 2-1A).  The sequence from the major 
globin locus was assembled from fully sequenced BACs and phage artificial chromosomes 
(PACs) available from the zebrafish genome sequencing project at the Sanger Genome 
Sequencing Center (GenBank ID: AC103581, GenBank ID: AL953863, GenBank ID: 
BX004811 and GenBank ID: CU464181) based on overlapping sequences among these genomic 
clones and their encoded globins. Additional sequenced BACs contain different numbers of 
globin genes, such as AL845551 and AL929176, indicating the presence of various globin locus 
haplotypes within the population. Figure 2-1A likely represents a summary of more than one 
haplotype of the globin region in individual zebrafish that were used to make BAC and PAC 
libraries (BUSM1, CHORI, CH73, and DanioKey). The major globin locus is syntenic to human  
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Figure 2-1.  Major and minor zebrafish chromosomal loci and protein sequences.   
(A) The major and minor zebrafish globin loci are located on chromosome 3 and 12 respectively.  
The major locus was assembled by aligning bacterial artificial chromosomes (BAC) and phage 
artificial chromosomes (PAC), AC103581, AL953863, BX004811 and CU464181, and contains 
13 globin genes.  The minor locus was assembled by aligning 2 BACs, CR352324 and 
BX572076, and contains 4 globin genes.  The timing of expression is denoted by “embryonic,” 
“embryonic/larval,” and “adult.”The surrounding regions included are syntenic with other teleost 
and mammalian species (“Results”).  The scale indicated the distance of the region from the 
beginning of rhbdf1 on both loci.  (B) The human α-globin locus, adapted from Higgs and Wood 
[182], is syntenic with both the major and minor zebrafish globin loci.  (C) Analysis of the 
similarity of the various globins, broken into α- and β-globins, by protein sequence.  Phylogenic 
analysis was performed using the Clustal W method (MegAlign; DNASTAR).  Shades of gray 
indicate level of conservation at the amino acid level.
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Figure 2-1.  (Continued) 
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chromosome 16 which contains the α-globin locus (Figure 2-1B).  The adjacent genes around the 
zebrafish major locus share many similarities with the human α-globin locus [33,34].  These 
include rhbdf1 (c16orf8), mpg, nprl3 (c16orf35), and the kank2 (flj20004; an ankyrin-like gene).  
The LCR is found within an intron of the adjacent nprl3 gene [199].  There are several 
differences in the zebrafish major locus compared to mammals.  First, genes are primarily found 
in α/β-globin pairs with a head-to-head orientation. This gene distribution implicates a primitive 
mechanism to coordinate equal expression of the two globin genes:  utilization of a single 
common promoter and shared enhancer.  Second, in the zebrafish the adult globin cluster is 
located closer to the putative locus control region (“The Putative α-LCR and Proximal globin 
Promoter Confers Erythroid Specific Expression”) than the embryonic/larval cluster.  This is in 
contrast to humans and mice where the globin genes are expressed in the order of their position 
within the locus, with the earliest expressed globins closest to the LCR [38].   
The minor locus is covered on two BACs, CR352324 and BX572076, and each contains 
the same four globins.  This locus is less syntenic with the mammalian globin loci, while 
remaining syntenic with other fish globin loci.  Similar to Fugu it shares the rhbdf1 gene that is 
also present at the major globin locus [34].  This locus is flanked on the other side by the aqp8 
and lcmt genes (Figure 2-1), with the lcmt gene also being a conserved flanking gene with Fugu 
[34].  Like the major locus, genes are also arranged in pairs; however, only the intermediate 
expressed globins αe5 and βe2 are arranged in a head-to-head orientation.  The αe4 and βe3 pair is 
arranged in a tail-to-tail fashion.  
Genome wide survey of globin coding loci, on Zv9 and available BAC sequences, has 
identified 17 coding regions that harbor conserved globin genes (Table 2-2). Through sequence 
similarity analysis at both the nucleotide and amino acid levels (Figure 2-1C), 11 unique globin 
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Table 2-2.  Unique identifiers and chromosomal coordinates for zebrafish globin genes.  
Gene 
NCBI Official 
Symbol 
Sequence 
Accession # ZFIN ID 
Chromosome 
Coordinates Ensemble Gene ID 
αa1a/b hbaa1 NM_131257 ZDB-GENE-980526-79 3:55951784-55952605 ENSDARG00000079078 
  
NM_001033093 
 
3:55956810-55957634 
 αa2 si:ch211-5k11.6 NM_001013461 ZDB-GENE-081104-38 3:55945257-55946071 ENSDARG00000069735 
αe1a/b/c hbae1 NM_182940 ZDB-GENE-980526-80 3:55972039-55972738 ENSDARG00000089475 
    
3:55979221-55979920 
 
    
3:55990381-55990796 
 αe3 hbae3 BC071507 ZDB-GENE-990706-3 3:55998262-55999416 ENSDARG00000079305 
αe4 
 
zgc:163057 
(hbq1) NM_001082834.1 ZDB-GENE-070410-131 12:21688580-21689767 ENSDARG00000045144 
αe5 
 
LOC561790  
(hbz) EH450566 ZDB-GENE-101028-1 12:21704893-21706037 ENSDARG00000045142 
βa1a/b ba1 NM_131020 ZDB-GENE-990415-18 3:55955117-55955918 ENSDARG00000089087 
    
3:55950129-55950930 
 
βa2 zgc:92880 NM_001003431 
ZFIN:ZDB-GENE-040801-
164 3:55942902-55943621 ENSDARG00000069734 
βe1a/b/c hbbe1.1 NM_198073 ZDB-GENE-030616-7 3:55974334-55975111 ENSDARG00000089963 
    
3:55965769-55966546 
 
    
3:55982961-55983724 
 βe2 hbbe2 NM_212846 ZDB-GENE-040702-1 12:21702360-21703066 ENSDARG00000045143 
βe3 hbbe3 NM_001015058 ZDB-GENE-980526-287 12:21691962-21693036 ENSDARG00000038147 
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genes were identified with evidence from existing cDNA sequences.  Several of the genes have 
been duplicated or triplicated and share identical sequence at the nucleotide and amino acid 
level.  Comparative analysis of their proximal promoters also shows that they are identical (data 
not shown).  The majority of these gene species have been previously identified in other studies 
for embryonic [30] and adult zebrafish globins [32].  Based on phylogenetic analysis, these 
globins are grouped into α- and β-globin branches. Based on sequence diversity of BACs 
containing globin genes, comparison of different strains reveals the presence of different 
haplotypes of adult globins (data not shown).  New globins have been identified on the minor 
locus using a sequence search.  These globin genes, αe4, αe5, βe2 and βe3, were not previously 
analyzed for their sequence similarity and gene expression.  Both βe2 and βe3 group with the 
previously known zebrafish β-globin genes based on amino acid sequence.  Similarly, αe5 groups 
with the previously known zebrafish α-globin genes.  αe4 is the most divergent of all the newly 
analyzed globin genes and, apart from teleosts, is the most similar to the αD globin found in 
chickens. The unique number of globins present and similar organization of the zebrafish globin 
loci is mostly likely the result of genome duplication(s). 
Globin gene expression during development identifies two globin switches 
To characterize the developmental globin switching process, the expression of the globin 
genes was followed in embryos, juveniles and adult fish up to 32 days post fertilization (dpf), 
and then again assessed at one year of age.  Total RNA samples were analyzed with quantitative 
real-time PCR (qPCR) primers designed to amplify specific globin species.   
The globin expression studies delineate three stages of expression (Figure 2-2).  The 
embryonic stage is defined by the expression of βe3, the only exclusively embryonic globin, with  
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Figure 2-2.  Relative globin expression levels throughout development.  
The relative expression level changes of the α-globin (A) genes and the β-globin genes (B) in the 
zebrafish are shown.  In both A and B, the approximate embryonic (emb), larval and adult stages 
of globin expression are denoted by shades of gray.  The first time point depicted is the 16 
somite stage.  Relative expression levels were determined by quantitative real-time PCR and 
normalized to band3.  The globin genes αe4 and αa2 are not depicted as no significant expression 
was detected at any of these time points. 
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substantial contribution from αe1, αe3 and βe1 (Figure 2-2 “emb” panel).  The first switch then 
appears to begin between 24 hpf and 36 hpf, marked by the sharp decrease in βe3.  The larval 
stage is characterized by increasing expression of βe2 and, in the later portion, αe5, two genes 
oriented head-to-head in the genome in the minor locus (Figure 2-1), as well as the maintained 
expression of many of the globins from the embryonic stage.  These embryonic globins begin to 
decrease as the larval globins peak near the end of this period.   The second switch that 
establishes the mature, adult globin expression, as defined by the expression pattern observed at 
1 year of age, is characterized by the decreasing expression of the embryonic and larval globins 
and the increasing expression of the nearly exclusively adult globins αa1 and βa1 (Figure 2-2).  
This switch begins around 22 dpf, with the continued decline of the embryonic/larval stage 
globins and the start of the decline of the larval globins αe5 and βe2.  The adult globin expression 
pattern is nearly completely established by 32 dpf.  The genes from the cluster closest to the 
Locus Control Region (LCR), αa1 and βa1, contributing the majority of hemoglobin for the adult 
fish and a smaller contribution from βa2.  For the first 5 dpf, we examined the expression of the 
globin genes by in situ hybridization (Figure 2-3).  These results support the qPCR results and 
provide further evidence there is a globin switch from the embryonic to larval stages in the 
zebrafish.  The decrease of βe3 expression between 48 hpf and 3 dpf observed in the qPCR data 
(Figure 2-2) is also observed by in situ hybridization as a loss of the staining between these two 
time points (Figure 2-3).  The increase in the expression of βe2 between the 16 s.s. and 5 dpf 
identified by qPCR is also evident in the increased intensity of the staining over the course of 
these time points by in situ hybridization.  Together, these gene expression studies demonstrate 
that the zebrafish has an embryonic to larval switch and a larval to adult globin switch.   
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Figure 2-3.  Globin expression by in situ hybridization through 5 dpf.   
Expression patterns of the α- (A) and β-globin (B) genes.  For detected genes, expression is seen 
in bilateral stripes at the 16ss, in the ICM at the 25ss and 24 hpf stage.  With the onset of 
circulation at 24 hpf, globin positive cells can be seen throughout the vasculature with probes for 
expressed globin genes, particularly in the vascular plexus of the caudal hematopoietic tissue.   
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Figure 2-3.  (Continued) 
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Analysis of the genomic structure of the globin loci  
To define long-range globin enhancers and promoters, DNase I hypersensivity mapping, 
the active H3K4 trimethylation (H3K4me3) mark was mapped and ChIP-seq analysis for the 
canonical erythrocyte transcription factor GATA1 [40] was carried out in mature adult 
erythrocytes, which are nucleated in the zebrafish.  DNase I and H3K4me3 peaks were observed 
at expected genes such as GATA1, SCL and KLF4 in comparison to the control liver cells 
(Figure 2-4).  As expected, the GATA1 ChIP-seq showed distinct peaks corresponding to the 
proximal promoters of the transcriptionally active adult globin genes.  Within both the major and 
minor globin loci, the HS are highly correlated with H3K4me3 within gene bodies, and the 
GATA1 sites show a restricted binding correlated with strong HS signals (Figure 2-4).  HS and 
H3k4me3 signals are evident through the body of the adult globins in the major locus and 
generally absent from those of the embryonic globins, consistent with the, respectively, high and 
low levels of expression of these gene in adult red cells (Figure 2-2).  These data indicate an 
open genomic structure at the adult globin promoters.  Within the globin gene cluster, the 
binding of GATA1 appears to be localized to the proximal promoters of the highly expressed 
adult globin genes in conjunction with elevated HS signal and H3K4me3 signal.  An additional 
strong HS peak that does not correspond with a GATA1 signal appears near the proximal 
promoter for βe1, the embryonic gene closest to the transcriptionally active adult globins.  As 
observed in other organisms, this HS may be playing a role in repressing the subsequent globins 
[200].  A similar pattern is observed in the minor locus (Figure 2-4); the only coding region with 
high levels of H3K4me3 and HS is αe4, for which no expression was detected.  A peak within the 
repressed region, as determined by qPCR expression (Figure 2-2), of βe2 and αe5 is also observed.   
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Figure 2-4.  Analysis of the chromosomal state of the major and minor globin loci.   
All tracks were mapped to Zv9 on the UCSU genome browser (http://genome.ucsc.edu/).  In 
some cases annotated genes were renamed in order to adhere to the naming convention, and in 
cases where a globin gene was not annotated, the UCSC BLAT tool was used to locate the ORFs 
included in the figure.  The shaded gray areas indicate the confirmed and putative regulatory 
regions in the major and minor loci respectively. 
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Figure 2-4.  (Continued) 
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These results are specific to red blood cells as the control liver cells do not exhibit any of these 
patterns.       
In addition to the HS, H3K4me3 and GATA1 sites within the globin gene cluster itself, a 
number of putative upstream regulatory elements in both loci were identified.  The gene adjacent 
to the globin coding sequences of the major locus, nprl3, which is also expressed in red cells, 
contains a number of HS.  One of these peaks spans a region of approximately 530 bp and 
contains a core region of approximately 200 bp that features NFE2, CACCC and functional 
GATA1 motif binding sites.  This region is located approximately 26 kb upstream of the nearest 
globin coding sequence (HS-26; gray box, Figure 2-4 “Major Globin Locus”).  This region 
shares similarity to MCS-R2 (HS-26 in mice and HS-40 in humans) [45].  The overall genomic 
structure of the minor locus appears to be less homologous to globin loci in higher vertebrates, 
but a number of putative regulatory sites were able to be detected.  Three peaks, two with strong 
H3K4me3 and HS signal and one HS without H3K4me3 signal, are spread across the locus 
(Figure 2-4). The first is located upstream of αe4, the second spanning the coding sequence of the 
gene and the third between βe2 and αe5.  All three contain numerous GATA1-, NF-E2- and 
CACC- binding motifs.  As in the major locus, the GATA1 binding is mainly localized to 
proximal promoters, though the genes are not active (Figure 2-4).  The strongest DNase I 
hypersensitive peak in the minor locus (gray box, Figure 2-4 “Minor Globin Locus”), located 
upstream of all the coding sequences, contains the characteristic binding motifs and coordinates 
with the strongest GATA1 peak, and it is therefore most likely the LCR for the minor locus.  
These measures of the genomic structure of the globin locus strongly indicate a role for these 
features in the overall regulation of globin expression and demarcating putative regulatory 
elements.   
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The Putative α-LCR and Proximal globin Promoter Confers Erythroid Specific Expression 
Due to the open chromatin and high degree of sequence homology to known globin 
regulatory regions (MCS-R2) the role of the HS-26 peak in the regulation of globin gene 
expression in zebrafish was further investigated.  The MCS-R2 regulatory site has been mapped 
in humans to a 300 bp region within the 5th intron of the nprl3, that contains GATA(1)-, NF-
E2/AP1- and CACC-binding motifs [38,182]; both the synteny and binding motifs are conserved 
in the zebrafish homologue, HS-26 (Figure 2-5A).  A similar region was identified through 
comparison to additional species [45,201]. This region has been identified as being sufficient for 
robust and specific reporter expression in red blood cells [40].    
In order to functionally test the ability of the putative zebrafish regulatory region HS-26 
to confer robust, erythroid-specific expression in vivo, a fragment from a bacterial artificial 
chromosome (CH211-113F11; AL953863) containing HS-26 from the 5th intron of nprl3 as well 
as a portion of the α/βa2 bidirectional proximal promoter were cloned into GFP reporter 
constructs and assessed their expression in vivo (Figure 2-5B).  Transgenic embryos were grown 
to adulthood and transgenic lines established.  Multiple lines were monitored and found to have 
robust erythroid specific visible GFP expression beginning at the 16 somite stage in bilateral 
stripes in the posterior mesoderm (Figure 2-5C).  At 22 hpf, the ICM region, the site of primitive 
hematopoiesis, is label with GFP (Figure 2-5D).  At 24 hpf, these GFP positive cells enter 
circulation and persist through adulthood (Figure 2-5E, F).  The specificity of the GFP 
expression to mature erythrocytes was confirmed by FACS analysis of adult zebrafish peripheral 
blood (Figure 2-5G).  GFP expression in erythrocytes is visible from the 16 somite stage to 
adulthood, demonstrating that the reporter construct does not “switch.”  In addition, expression 
of the GFP mRNA was assessed in order to directly compare the expression of the endogenous  
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Figure 2-5.  Generation and characterization of LCR-GFP transgenic zebrafish line.   
(A) Sequence and location of the HS-26 DNase I hypersensitivity site (HS-26; yellow rectangle) 
and locus control region (LCR; red rectangle) within the major globin locus.  The proximal 
globin promoter used is indicated with a red star.  Shaded boxes indicate binding motifs for 
canonical erythrocyte transcription factors.  (B) Representation of the vectors assembled from 
genomic fragments and the resulting GFP expression patterns.  Fluorescent images of LCR-GFP 
transgenic zebrafish embryos at 16ss, 22 hpf and 36 hpf respectively (C-E).  (F) Fluorescent 
image of the flank of an adult LCR-GFP transgenic zebrafish.  (G) Red blood cell gate as 
determined by forward and side scatter for peripheral blood, and the analysis of the percent of 
GFP positive red blood cells in an LCR-GFP transgenic adult (green) versus in a wild-type adult 
(red). 
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Figure 2-5.  (Continued) 
 
 
 
 
 
 57 
 
globins versus that of the transgene.  GFP mRNA expression can be detected beginning at 
approximately the 12 somite stage, which coincides with the onset of endogenous globin 
expression [30] (Figure 2-6).   
Additional constructs were assembled to confirm HS-26 as the functional globin 
enhancer.  The various constructs were injected at the one cell stage, the embryos were allowed 
to develop until the 24 hpf stage and observed under a fluorescent microscope.  The ability of the 
α/βa2-bidirectional promoter to drive erythroid expression in the absence of the enhancer was 
tested by injecting the reporter construct without the putative LCR region.  None (0%; 0/50) of 
the injected embryos expressed visible GFP expression, while 92% (22/25) of those injected with 
the construct containing the full LCR expressed GFP (data not shown).  Two constructs were 
designed with a truncated LCR region containing either HS-26, as defined by the bounds of the 
DNase I peak (Figure 2-4), or the fraction of HS-26 located under the GATA1 peak (Figure 2-4) 
driving GFP under the control of the α/βa2-bidirectional promoter.  Injection of each construct, in 
parallel with an mCherry reporter plasmid to control for injection efficiency, showed robust ICM 
GFP expression in 100% (50/50; 50/50) of productively injected embryos.  Replacing the 
zebrafish α/βa2-bidirectional promoter with a minimal promoter derived from the mouse β-globin 
locus confirmed the enhancer ability of both the DNase and GATA1 peaks.  GFP expression was 
observed in the ICM of 100% (50/50) of embryos productively injected with the GATA1 peak 
enhancer/minimal promoter construct and 94% (47/50) of embryos injected with the DNase 
peak/minimal promoter construct (Figure 2-7).  Conversely, 82% (41/50) of embryos 
productively injected with LCRP1/P2-MinPro-GFP, which contains the full LCR except for the 
DNase I peak, did not express GFP in the ICM.  This demonstrates that the functional component 
of the full LCR region is contained within the DNase I peak.  The ability of HS-26 to confer  
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Figure 2-6.  GFP mRNA expression in LCR-GFP transgenic zebrafish line.   
In situ hybridization was performed to detect GFP RNA expression in the LCR-GFP transgenic 
zebrafish line as RNA expression precedes visible GFP fluorescence.  This was performed at the 
12 s.s. (A), 13 s.s. (B), 16 s.s. (C), 18 s.s. (D), 24 hpf (E) and 48 hpf (F) stages. 
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Figure 2-7.  Functional characterization of the LCR in transiently injected embryos.   
(A) Summary of the transgenic constructs injected including the enhancer element, promoter and 
vector backbone.  All vectors listed contain a GFP reporter open reading frame.  Bright field, 
GFP and composite images of representative Gata1Peak-LCR-MinPro-GFP (B) and 
DNaseIPeak-LCR-MinPro-GFP (C) embryos.  1The # Observed refers to all embryos observed 
from the injected clutch.  2The # Observed refers to the number of productively injected embryos 
as determined by expression by an mCherry reporter plasmid. 
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Figure 2-7.  (Continued)   
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robust, specific expression in vivo confirms that the region is the LCR for the major globin locus 
and its functional homology to MSC-R2.    
Discussion 
Globin gene regulation serves as a paradigm for the study of gene expression.  The 
zebrafish offers a genetic model to study globin gene switching in vivo.  Although the erythroid 
program in zebrafish utilizes many of the same transcription factors as mammals, the unique 
structure of the fish globin loci ensures globin chain balance by regulating pairs of globin genes.  
Our analysis of the globin locus in zebrafish demonstrates a high level of synteny between the 
teleost globin loci and the mammalian α-globin locus.  The LCR is very well conserved based on 
functional studies.  The switching patterns include a switch from embryonic to larval, and from 
larval to adult globins.  Surprisingly, the genomic structure of the loci and the binding of a 
canonical erythrocyte transcription factor are very similar between mammals and fish, despite 
the overall lack of primary DNA sequence conservation. This suggests that the overall genomic 
structure, including the binding of transcription factors, is more critical for globin gene 
expression than strict sequence conservation.   
Our work supports the hypothesis that the ancestral locus is an α-globin locus [33,34].  
The presence of both α- and β-like globin genes on both the major and minor loci may place the 
zebrafish closer to this ancestral locus than the puffer fish (Fugu rubripes), where one locus 
contains only α-like genes, more similar to the organizational structure found in mammals.  The 
arrangement of the globin genes within the loci also implies a bi-directional promoter located 
between an α- and β-like gene as an ancestral mechanism for obtaining comparable levels of α- 
and β-like Globin protein.  This is also supported by the localization of the GATA1 peaks 
(Figure 2-4) to these putative promoter regions in major locus.  The mammalian globin loci are 
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arranged such that, for the predominant globins, the genes are temporally expressed in the order 
in which they are present in the genome [40,45].  Within the zebrafish genome, the genes are 
grouped into clusters of embryonic, embryonic/larval, larval and adult gene expression, and 
while the importance of physical location with respect to the LCR is conserved, the orientation is 
reversed for the major locus (Figures 2-1).  Globin switching occurs in fish and utilizes the LCR 
elements to interact with specific regulatory elements near the individual globin genes.           
The conservation of the regulatory network responsible for controlling globin switching, 
including the conservation of the transcription factors, the primary sequence of their binding site, 
the location of these site and their affects on transcriptional effect on other regulators and the 
globin gene themselves, establishes the similarity between the overall process of globin 
production in zebrafish and higher mammals.  At approximately 16 s.s. in the bilateral stripes of 
the developing embryo, the primitive erythrocytes have a high expression of the embryonic 
globin genes αe1, αe3, βe1 and βe3 (Figure 2-2, 2-3).  Around 24 hours post fertilization (hpf), 
primitive proerythroblasts enter circulation [27], expressing the same embryonic globins, but 
with ratios different than those present at earlier time points.  These cells presumably undergo 
“maturational” globin switching [26], as the globin expression of the embryo continues to change 
prior to the emergence of red blood cells derived from the next wave.  These cells continue to 
mature in circulation and are the only circulating red cell population through 4 dpf [28], but can 
contribute past 7 dpf [27].  Between 1 dpf and 2 dpf, the ratios of the embryonic globins 
previously expressed continue to change, and through 4 dpf βe3’s contribution drops while βe2 
expression increases.  These changes coincide with the emergence of the erythromyeloid 
progenitor (EMP) population, which is responsible for generating the next wave of red blood 
cells to enter circulation [202].  Mature cells begin to enter circulation about 36 hpf, but 
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contribute to the globin expression of the whole embryo prior to this.  Through this time period 
maturational switching as well as the evolving ratio of primitive to EMP cells are most likely 
affecting the global globin profile.   The definitive hematopoietic stem cells are specified as early 
as 24 hpf but do not contribute to the mature red blood cell pool until approximately 10-14 dpf, 
having already migrated from the AGM to the caudal hematopoietic tissue (CHT), but may be 
contributing to the whole embryo globin profile prior to entering circulation.  HSCs arriving 
from the CHT begin to seed the pronephros beginning around 4 dpf, with the definitive 
hematopoietic activity detectable short thereafter.  This will provide full multilineage 
hematopoietic support for the remainder of the animal’s life [203].  Therefore, it is likely that the 
precipitous decrease in the embryonic globins between approximately 17 dpf and 26 dpf (Figure 
2-2) is the result of a decreasing contribution from the EMP wave erythrocytes, and an unknown 
contribution from maturational switching.  The larval globins αe5 and βe2 peak at a distinct time 
period.  Definitive erythrocytes may not undergo maturational globin switching as the increase in 
αa1 and βa1 coincides approximately with the increasing contribution of definitive erythrocytes to 
circulation.  The overlapping of these distinct cell populations in the embryo as well as 
remaining gaps in our understanding of zebrafish hematopoiesis do not allow us to fully resolve 
the nature of each observed switch.  Our data support that both maturational and cellular 
switching processes contribute to the changes in the overall globin expression observed 
throughout development.          
The functional identification of the LCR in the zebrafish through the use of DNase I 
hypersensitivity mapping and GATA1 ChIP demonstrates the power of this technique to quickly 
identify key hematopoietic regulatory sequences.  The identification of novel co-localized peaks 
within mature red cells may indicate the importance of such regions.  In addition, the comparison 
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of such dataset between red cell from multiple waves or maturational stages could provide 
insights into the dynamics of particular regions and their putative relevance to the functional 
changes occurring.  These techniques are complementary to and not redundant with sequence 
analysis techniques as the rearrangement of elements can obscure sequence similarity despite 
functional similarity.  In addition, regions identified by sequence similarity may not be identified 
by the genomic state of the region (MCS-E2) [199], and regions identified by sequence 
homology may not be as robust regulatory regions as those identified by genomic state [201].           
The well documented [33,34] high level of syntenic conservation of the organization of 
the globin locus throughout evolution was able to both inform our work and is highly suggestive 
that there can be a fluid translation of information between zebrafish and mammalian systems.  
The sequence conservation observed through our analysis and annotation of both the coding and 
some non-coding regions of the loci concur with the assessment of previous work that both the 
synteny and regulatory regions have changed little over 500 million years of evolution [40].  In 
particular, the sequence conservation of the cis-regulatory elements, including GATA-1, NF-E2 
and SCL binding motifs, suggest functional conservation in the trans-regulatory networks 
interacting with the cis elements and demonstrate the evolutionary constraints on this essential 
process.  The syntenic conservation of flanking genes furthers this point, including nprl3 which 
contains the LCR in mouse, humans, pufferfish, medaka [45,201] as well as the regulatory 
element identified here.  
The identification of the functional LCR in zebrafish can facilitate the dissection of the 
functional role(s) of surrounding regions in the process of globin switching.  With the relative 
ease of transgenics in the zebrafish, fragments of DNA can be coupled to GFP and analyzed in 
vivo in the context of wildtype or hematopoietic mutants or morphants.  The transgenic construct 
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generated here recapitulates endogenous globin expression (Figure 2-5C, 2-1) and mimics the 
temporal expression changes observed for analogous constructs in the mammalian system 
[49,204]. Assessing the affects of alterations to the construct can, as shown here, be more easily 
tested in the zebrafish than a mammalian model.  The loci’s genomic context, presence of 
“intervening” sequence between the LCR and proximal promoter/coding sequence and the 
absence of additional genes in the region have all been investigated and/or shown to have an 
effect on globin switching [35,38,40,42,46,170,205].  Determining the role(s) of these additional 
regulatory elements can provide a better understanding of globin switching.  For instance, it is 
known that the zinfandel mutation (zin), which has been linked to the major globin locus, alters 
embryonic globin expression from both loci [30].  This mutation is likely in a critical regulatory 
element, and identifying the mutation and its role in the regulatory network using this 
information and these tools will shed light on the broader process of globin switching. 
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The Wnt and thyroid hormone receptor pathways modulate globin gene expression in zebrafish 
and human systems 
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Abstract 
Hemoglobin switching is a highly regulated set of molecular changes that alter the 
protein components of the oxygen carrying molecule hemoglobin throughout development.  The 
process has been studied since its discovery in the 19th century as a model of general gene 
regulation and because of its potential clinical implications for the treatment of the 
hemoglobinopathies.  However, the process is still not completely understood.  To identify new 
potential regulators of globin expression, we performed both a morpholino knockdown and a 
high throughput chemical screen for increased adult globin expression in 24 hpf zebrafish.  We 
identified four genes and 52 chemicals that alter normal globin expression.  The combined 
knockdown of two of the genes identified, tcf7l2 and ncoa1, robustly and significantly increased 
the number of adult globin positive cells.  Similarly, two chemicals identified, XAV939, a Wnt 
pathway inhibitor, and L-thyroxine (T4), thyroid hormone, individually and in combination 
significantly increased adult globin expression in embryos. Further analysis of the thyroid 
hormone pathway showed it specifically induced adult globin mRNA and protein without 
affecting general development or red cell production.  Inhibition of the thyroid hormone receptor 
pathway in adult zebrafish increased embryonic and larval globin expression, which indicates the 
pathway plays a role in the maintenance of the adult state.  T4 treatment of fetal globin-
expressing K562 and differentiated human fetal CD34+ cells increased levels of adult β-globin, 
demonstrating the role of this pathway in globin switching is conserved in mammals.  ChIP-seq 
analyses from both zebrafish and humans, taken together with the genetic and chemical biologic 
results, strongly suggest that thyroid hormone receptor activation directly alters the chromatin 
structure of the globin locus.  My work defined novel roles for two pathways in globin 
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regulation, and provides strong support for these pathways to be investigated as clinical targets 
for hemoglobinopathy therapies.  
Introduction 
Globin is the protein component of hemoglobin, the critical oxygen carrying molecule 
responsible for supplying oxygen to the tissues of all vertebrates [24].  Hemoglobin switching is 
a critical developmental process during which the complement of globin genes that an organism 
expresses is altered by a tightly regulated molecular process to meet its changing needs during 
embryonic, fetal, and adult life [38,171,199].  Many upstream pathways that regulate red cell 
specification, development, and differentiation also influence the molecular environment in 
which globin expression occurs, but the process is ultimately regulated directly at globin loci.  
An upstream enhancer known as the locus control region (LCR) plays a particularly important 
role within the group of cis-regulatory elements modulating the expression of globin genes, and 
contains a number of DNase I hypersensitive sites that are essential to its proper function 
[38,98,206,207].  Hemoglobin and its regulation have been studied in a large range of organisms 
from single-celled species to humans [33], and significant conservation has been observed 
including between frogs [208], fish [34,209], mice, and humans [38].  Previous work from our 
lab has also demonstrated this conservation of cis- and trans-regulatory elements in the zebrafish 
[3,30,32,169], making the zebrafish a suitable system to further investigate globin switching.     
The normal regulation of this process is disrupted in a collection of clinical disorders 
known as the hemoglobinopathies [210–212], which remain a major health concern worldwide 
[176,177].  For a number of these disorders, altering globin expression can helps to improve the 
clinical course of their disease.  For example, increasing γ-globin, typically a fetal globin, 
expression in sickle cell patients can ameliorate many of the symptoms of their disease [79,176].  
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By better understanding the endogenous genes, pathways, and mechanisms that regulate 
developmental globin switching, it may illuminate additional potential ways to clinically treat 
one or more of these disorders.   
The regulatory pathways that may directly influence hemoglobin switching in humans 
have been studied using a number of different model systems including cell culture [81,213], 
mice [10], transgenic mice [52] and humans [38].  Work in these systems has yielded significant 
progress towards a greater level of understanding, including the elucidation of the critical role of  
BCL11a in fetal globin suppression [63,64].  However, gaps in our understanding remain that are 
addressable in additional model systems.  Previous work from our lab has helped to establish the 
zebrafish as another suitable model system for the study of conserved hemoglobin regulatory 
pathways [169].  This makes additional avenues of investigation available, such as large scale 
knockdown and chemical screening in a whole organism, which can facilitate additional 
discoveries [109,110].   
The Wnt pathway is a large, complex signaling pathway critical to the normal 
development of a number of tissues in a number of species [139,141,214].  This includes 
essential functions in the hematopoietic system [142,143].  One of the many proteins involved in 
the Wnt pathway is the transcription factor tcf7l2 (Tcf4), which, binds to and modulates the 
expression of Wnt target genes [137].  Despite this pathway’s known role in general 
development, there is no specific role known for Wnt in globin gene switching or regulation.   
The nuclear hormone receptor pathway is a large, complex superfamily with known 
critical roles in a wide range of tissues and contexts, including general organismal development 
[146].  Specifically, the thyroid hormone receptor pathway plays a role in the metamorphosis of 
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amphibians and teleosts [155,215], as well as postembryonic remodeling of some mammalian 
species such as mice and humans [159].  In some cases, such as that of the frog, this has been 
directly linked to globin switching [158].  However, for most systems the links between thyroid 
hormone and development as well as between development and globin switching are known, but 
the direct link between thyroid hormone and globin gene expression has not been examined.  The 
thyroid hormone receptor pathway and the Wnt pathway interact in a number of systems and 
tissues [165–168], but this interaction has not been shown to influence globin gene expression, 
directly or indirectly.     
Here, we demonstrate that both the Wnt and thyroid hormone receptor pathways are 
involved in the regulation of globin gene expression.  In addition to the ability of both pathways 
to modulate expression independently, we demonstrate that the pathways work together to 
influence the globin expression pattern.  In the zebrafish embryo, a specific increase of adult 
globin genes is observed with activation of the thyroid hormone pathway and inhibition of the 
Wnt pathway at the mRNA level and thyroid hormone pathway activation at the protein level.  
The particularly robust affect of thyroid hormone pathway activation also translates to zebrafish 
larva and human K562 and differentiated primary fetal CD34+ cells.  We have also demonstrated 
that thyroid hormone is necessary for the maintenance of adult globin expression in adult 
zebrafish.  This has potential clinical implications for increasing HbF in humans and the 
treatment of hemoglobinopathies.  ChIP-Seq analysis supports that this pathway is acting directly 
on the globin locus.  NCOA1, RXRα, and TRβ are bound to a number of critical DNase I 
hypersensitive regions in the LCRs of both the α- and β-globin in human erythroid cells, and 
RXRα is bound to multiple bidirectional promoters in adult zebrafish peripheral blood and 
associated with key changes to H3K27ac within the globin clusters.  These data clearly 
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demonstrate that both the Wnt and thyroid hormone receptor pathways regulate globin 
expression, with the thyroid hormone receptor acting directly on the locus to establish and 
maintain adult globin expression.          
Materials and Methods 
Zebrafish maintenance 
Zebrafish were staged, raised, and maintained as previously described [188,189].  All 
zebrafish experiments and procedures were performed as approved by the Boston Children’s 
Hospital institutional Animal Care and Use Committee.   
Mircoarray analysis 
Previously generated raw microarray data was obtained [216] and analyzed using the 
ArrayStar software package (DNASTAR, Madison, WI).  When comparing data sets between 
waves (primitive, fetal definitive, adult definitive), all replicates and erythroid maturational 
stages (proerythroblasts, basophilic erythroblasts, orthochromatic/polychromatic erythroblasts, 
reticulocytes) were combined and treated as replicates.  A p-value<0.01 and a fold change of at 
least 8 were used to initially define differentially regulated genes.  Gene Ontology (GO) terms 
were used to identify transcription factors within the list of differentially regulated genes [217].  
From these transcription factors, a 2 fold cut off was used to determine if gene expression 
changed between each pair of waves (increase, decrease, no change), from which a simplified 
expression pattern of the gene over developmental time was determined.      
Morpholino injection 
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Morpholinos utilized in the knockdown screen were designed, synthesized (Gene-Tools, 
Philomath, OR) and injected as previously described [110] with the exception of Pbx1a, Jun, 
Lmx1b.1, Lmx1b.2, Prox1, and Hif1ab for which the designs have been previously described 
[218–222].         
Chemical screening 
The ICCB Biomol Bioactives (480 compounds), the NIH Clinical Collection (760 
compounds), the Lopac library, and the Small Biomol libraries were screened.  Zebrafish 
embryos were collected from specially designed large breading tanks [223]. The unfertilized and 
damaged embryos were sorted out and 10 embryos per well were added to 96 well mesh bottom 
plates submerged in E3.  At 50% epiboly the plates were transferred to 96 well receiver plates 
containing 0.3% DMSO in E3 media with a 1:300 dilution of a chemical from the library.  The 
embryos were pronase-treated, fixed, and processed for ISH at 24hpf.  The effects of chemicals 
were scored under a bright-field stereo microscopy and a prioritized chemical list was generated 
for compounds that cause the most significant increases. 
Drug treatments 
T4 treatments were carried out using L-Thyroxine (T4; Sigma, St. Louis, MO).  A master 
stock of 5 mM T4 dissolved in dimethyl sulfoxide (DMSO; Catalog #D5879, Sigma) and 150 
uM NaOH was diluted in additional DMSO to generate the working stock, which was then 
diluted 1:100 in E3 and applied to the embryos or larva.  An equal dilution of DMSO was used 
as the vehicle treatment.  A master stock of 10 mM XAV939 (Catalog#3748, Tocris, Bristol, 
United Kingdom) dissolved in DMSO was diluted in additional DMSO to generate a working 
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stock, which was then diluted 1:100 in E3 and applied to the embryos or larva.  An equal dilution 
of DMSO was used as the vehicle treatment. 
Larval red cell collection 
Larval peripheral blood was collected by cutting individual larva posterior to the yolk sac 
extension while the larva was immersed in 1X Dulbecco’s phosphate buffered saline (Catalog # 
D8537, Life Technologies, Grand Island, NY) and heparin (1 USP/mL, Catalog #2106, Sigma) 
using 30G needles (Catalog #305106, Becton, Dickinson and Company, Franklin Lakes, NJ). 
Dronedarone injections 
A master stock of 50 mM dronedarone (Dron; Catalog #D9696, Sigma) dissolved in 
DMSO was diluted in additional DMSO to generate the working stock, which was then diluted in 
PBS to generate the injection dose with final concentrations of 5, 8, or 15 µM (30% DMSO final 
concentration).  Injections were performed once per day for 4 days, approximately 24 hours 
apart, by retro-orbital injection [224] in alternating eyes.  Peripheral blood was collected by heart 
puncture.  Kidney marrow was collected by dissection followed by dissociation and filtering 
though a 40 µM filter.      
Whole mount antibody staining 
Whole mount fluorescent antibody staining was performed using standard procedures.  
Briefly, embryo were fixed in 4% paraformaldehyde, permeabilized with proteinase K (10 
µg/mL in PBS), blocked in 10% lamb serum, incubated overnight at 4 °C with primary antibody, 
and incubated with a fluorescent secondary antibody.  Samples were washed between each step 
with 0.8% Triton (Catalog #T8787, Sigma, St. Louis, MO) in PBS.  Primary antibodies used 
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were the custom zebrafish adult globin antibody (1:500) and Anti-Hbbe-1.1 (NT), Z-Fish (1:500; 
Catalog #55608, Anaspec, Fremont, CA).  Secondary antibodies used were Alexa Fluor® 488 
Goat Anti-Mouse IgG (H+L) Antibody, highly cross-adsorbed (1:2000; Catalog #A11029, Life 
Technologies, Grand Island, NY) and Alexa Fluor® 594 Goat Anti-Rabbit IgG (H+L) Antibody 
(1:2000; Catalog #A11012, Life Technologies).     
Blood smear antibody staining 
Immunofluorescence on zebrafish peripheral blood was completed using standard 
protocols.  Briefly, once cells were collected they were dried onto Poly-L-Lysine Coated 
Microscope Slides (Catalog #22247, Polysciences, Inc., Warrington, PA) in PBS.  Samples were 
then fixed in 4% paraformaldehyde for 30 minutes, blocked in a 10% lamb serum/1% DMSO 
solution, incubated overnight at 4 °C with primary antibody, re-blocked, and incubated with a 
fluorescent secondary antibody.  Samples were washed between each step with 0.1% Triton 
(Catalog #T8787, Sigma, St. Louis, MO) in PBS.  4',6-Diamidino-2-Phenylindole, Dilactate 
(DAPI; Catalog #D3571, Life Technologies, Grand Island, NY) at 1mg/L was also included prior 
to final washes in PBS to mark nuclei.  Primary antibodies used were the custom zebrafish adult 
globin antibody (1:500) and Anti-Hbbe-1.1 (NT), Z-Fish (1:500; Catalog #55608, Anaspec, 
Fremont, CA).  Secondary antibodies used were Alexa Fluor® 488 Goat Anti-Mouse IgG (H+L) 
Antibody, highly cross-adsorbed (1:2000; Catalog #A11029, Life Technologies, Grand Island, 
NY), Alexa Fluor® 594 Goat Anti-Rabbit IgG (H+L) Antibody (1:2000; Catalog #A11012, Life 
Technologies), Alexa Fluor® 568 Goat Anti-Mouse IgG (H+L) Antibody (1:2000; Catalog 
#A11004, Life Technologies, Grand Island, NY), and Alexa Fluor® 488 Goat Anti-Rabbit IgG 
(H+L) Antibody (1:2000; Catalog #A11008, Life Technologies).  Images were captured using a 
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Nikon NiE C2Si upright confocal microscope with a 40x 0.8NA objective.  Quantification was 
carried out using ImageJ software [225].     
Cell culture 
K562 cells were maintained in IMDM media with 10% Fetal bovine serum (FBS) and 
Pen/Strep.  Human fetal CD34+ cells were obtained from Novogenix as frozen vials. These cells 
were expanded in StemSpan SFEM and CC100 cytokine (Stem Cell Technologies, Vancouver, 
Canada) for 6 days.  After expansion, cells were differentiated toward the erythroid lineage using 
a previously described protocol [226]. 
For T4 treatments the serum was charcoal filtered to eliminate endogenous hormones.  3 
g of activated charcoal (Catalog# C-5260, Sigma) was mixed with 100 ml of serum and 
incubated for 2hrs.  The serum was then ultracentrifuged for 20min @ 25,000 rpm and the 
supernatant filtered through a 0.22 µm filter.   
Monoclonal antibody generation 
Female BALB/c, C56BL/6 and Swiss-Webster mice, 4–8 weeks old, were purchased 
from Charles River Laboratories (Wilmington, MA).  The mice were initially immunized 
subcutaneously with 100 ug purified adult zebrafish peripheral blood lysate in Dulbecco’s 
phosphate-buffered saline (PBS; Invitrogen, NY) and emulsified with an equal volume of 
complete Freund’s adjuvant (Sigma Chemical Company, St Louis, MO).  Two additional 
intraperitoneal immunizations of 50 ug were mixed 1:1 with incomplete Freund’s adjuvant 
(Sigma Chemical Company, St Louis, MO) were given 2 and 4 weeks later. Ten days following 
the last immunization, a bleed was obtained by retro-orbital bleeding to check the antibody titer.  
Mouse #386-2 (C57BL/6) was intravenously boosted with 50 ug purified lysate 3 days prior 
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hybridoma fusion.  The remaining two mice were given two additional boosts emulsified with an 
equal volume of Hunter’s Titermax Gold adjuvant (Sigma Chemical Company, St Louis, MO).  
Another bleed was obtained 10 days after the last immunization and the titer checked.  To further 
attempt to increase the titer, another two intraperitoneal immunizations, two weeks apart were 
given emulsified with an equal volume of Hunter’s Titermax Gold + CpG (20 ug/mouse; 
InvivoGen, San Diego, CA) followed by two final intraperitoneal immunizations emulsified with 
an equal volume of incomplete Freund’s adjuvant + CpG (20 ug/mouse). Mouse #386-3 (Swiss-
Webster) was intravenously boosted with 50 ug purified lysate 3 days prior hybridoma fusion.  
All animals were acquired and maintained in accordance with the guidelines of the Institutional 
Animal Care and Use Committees of Harvard Medical School and the Guide for the Care and 
Use of Laboratory Animals (Institute of Laboratory Animal Resources, National Research 
Council). 
The selected mice were rested for 4 weeks after the last immunization and then boosted 
by intravenous injection with 50 ug purified lysate in PBS. Four days later, the mice were 
sacrificed, and spleen and lymph node cell suspensions were prepared and washed with PBS. 
The cell suspensions were counted using a hemocytometer and mixed at a spleen:myeloma cell 
ratio of 2:1.  The SP 2/0 myeloma cells (ATCC No. CRL8-006, Rockville, MD) used are 
incapable of secreting either heavy or light immunoglobulin chains [227].  Cells were fused 
using polyethylene glycol 1450 (ATCC) into eight 96-well tissue culture plates suspended in 
HAT selection medium according to standard procedures [228].  Clones were screened using a 
combination of western blotting and blood smear antibody staining using larval, adult, and mixed 
samples for comparison.  A clone producing an IgG2a κ isoform specifically binding to adult 
zebrafish red cells was selected and used for antibody production.                 
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RNA isolation and cDNA preparation 
Pools of embryos or samples of tissue were collected and homogenized in Trizol reagent, 
Trizol LS reagent (Invitrogen, Carlsbad, CA), or using the RNEasy Plus Mini Kit (Qiagen, 
Germantown, MD).  For Trizol and Trizol LS, total RNA was isolated using the manufacturer’s 
protocol with the addition of GenElute LPA (Sigma-Aldrich, St. Louis, MO) as a carrier for 
small tissues samples.  For RNEasy samples, total RNA was isolated using the manufacturer’s 
protocol.  For all samples, SuperScript® III First-Strand Synthesis SuperMix for qRT-PCR 
(Invitrogen, Carlsbad, CA) was used to generate cDNA.          
Quantitative real-time PCR 
Quantitative real-time PCR (RT-PCR) was performed on a CFX384 Real-Time System 
with C1000™ Thermal Cycler (Bio-Rad, Hercules, CA) using SYBR Green Supermix (Bio-Rad).  
Zebrafish [169] and mammalian [69] globin primers have been previously described.  The 
ProbeFinder online software tool (Roche Diagnostics, Basel, Switzerland) was used to design all 
other zebrafish RT-PCR primers used.  Reactions were carried out in 5 μL; 2.5 μL of SYBR 
Green Supermix, 2 μL of diluted cDNA, and a final concentration of 200 nM of forward and 
reverse primers.  Analysis was performed using the Bio-Rad CFX Manager software, version 
3.1.  For all analysis of zebrafish red cell samples, slc4a1 was used as a control gene.  For all 
mammalian samples, a combination of GAPDH and β-actin was used as a control.  For all 
zebrafish whole embryo samples, gapdh was used.                  
In situ hybridization 
The whole-mount in situ hybridization (ISH) protocol was carried out as previously 
described [197] using antisense probes amplified from digested plasmids.  Scores for treatments 
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were determined by counting individual positive cells in the intermediate cell mass (ICM) of 
stained embryos at 24 hpf.  Up to 39 individual cells were counted, after which the cells became 
too numerous to count.  In initial treatments, these were classified and analyzed as “40.” In 
subsequent treatments, levels above 39 cells were subjectively categorized into six categories, 
which were classified and analyzed as “40”-“45.”    
RNA-Seq 
Samples were collected in Trizol reagent (Invitrogen, Carlsbad, CA), and RNA was 
purified according to the manufacturer’s instructions.  The RNA was further purified using the 
TURBO DNA-free Kit (Catalog #AM1907, Life Technologies, Grand Island, NY) and RNEasy 
Mini Kit (Catalog #74104, Qiagen,Valencia, CA).  Samples were submitted to the Whitehead 
Institute Genome Technology Core for library construction and sequencing (Cambridge, MA). 
To analyze the data Truseq adapter sequences and bases with quality scores < 20 were 
trimmed using cutadapt [229].  Trimmed reads were aligned using Tophat 2.0.5 [230] to build 
Zv9 of the zebrafish genome, using as annotations release 68 of the Ensembl gene annotations.  
A maximum of two mismatched bases per alignment was allowed.  Reads mapping to genes 
were counted with htseq-count version 0.5.3 [231] and differential expression was called 
between groups using DESeq [232], with sharingMode=“fit-only”.   
ChIP-Seq  
ChIP- seq was performed as previously described [169] with the following modifications.  
For the H3K27ac ChIP-seq in zebrafish larval red cells, the three step lysis was modified such 
that the cells were diluted in solution 3 and sonicated.  All samples were multiplexed using the 
NEBNext Multiplex Oligos for Illumina (Index Primers Set 1, E7335S, New England Biolabs, 
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Ipswich, MA) according to the manufacturer instructions.  Analysis of the K562 data sets was 
performed as previously described [145]. 
Zebrafish ChIP-seq data sets were aligned using Bowtie (version 0.12.2) [191] to build 
version Zv9/danRer7 of the zebrafish genome with parameters “-k 2 -m 2 -n 2”.  MACS version 
1.4.1 (Model-based analysis of ChIP-seq) [192] peak finding algorithm was used to identify 
regions of ChIP-seq enrichment over background.  A P-value threshold of enrichment of 1e-9 
was used for all data sets with parameters “--nomodel -g 1.4e+9 --keep-dup=2.”  To obtain the 
normalized read density of ChIP-seq data sets in any region, ChIP-seq reads aligning to each 
region were extended automatically by MACS and the density of reads per base pair (bp) was 
calculated.  The density of reads in each region was normalized to the total number of million 
mapped reads producing read density in units of reads per million mapped reads per bp 
(r.p.m./bp).  In order to determine the overlap between ChIP-seq datasets, a general linear model 
to identify regions with differential signal between different H3K27ac ChIP-seq profiles was 
adopted [233,234].  First, the set of genomic regions that were enriched for H3K27ac ChIP-seq 
signal in any one of the 3 data sets being considered were identified.  Regions from a data set 
that overlapped with regions from another data set by 1 bp were merged together to form a 
representative region that spans the combined genomic region.  For each region, the read density 
in reads per million per bp (r.p.m./bp) was calculated, and from this the relative read count of 
each region was obtained by multiplying read density by the length of the region.  The edgeR 
package was used to model the variations due to differences in signal between two ChIP-seq data 
sets [233]. Sequencing depth and upper-quantile techniques were used to normalize all three data 
sets together before common dispersions were estimated.  The statistical significance of 
differences between two ChIP-seq data sets was next calculated using an exact test and resulting 
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P values were subjected to Benjamini–Hochberg multiple testing correction (FDR). For 
robustness, only regions that were called “enriched” by MACS in one of the two datasets in the 
pair-wise comparisons were used for differential signal analyses.  The final regions with 
differential signal were required to have an absolute log2 fold change of normalized H3K27ac 
signal greater or equal to 1 and FDR less or equal to 0.1. 
All ChIP-seq results were visualized using the UCSC genome browser 
(http://genome.ucsc.edu). 
DNase I Hypersensitivity  
DNase I hypersensitivity analysis of K562 cells 
(wgEncodeUwDnaseSeqRawSignalRep1K562.wig.gz) was obtained from the ENCODE 
Consortium Data Coordination Center at UCSC [235] and visualized using the UCSC genome 
browser (http://genome.ucsc.edu).  The data was produced by the laboratory of John 
Stamatoyannopoulous (University of Washington). 
Results 
Identification of regulators of globin gene expression by knockdown screen 
In order to identify transcription factors that regulate globin expression, we tested 
whether globin expression could be altered by knocking down specific transcription factors with 
morpholinos in zebrafish embryos.  Changes in αa1 expression were selected as the screening 
assay because baseline expression in the embryos is extremely low at 24 hour postfertilization 
(hpf) and significant increases would clearly indicate a disruption the in normal globin switching 
process.  The adult α-globin gene αa1 is expressed at a low, nearly undetectable level in 24 hpf 
zebrafish embryos.  By in situ hybridization (ISH), expression remains nearly undetectable until 
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at least 5 days postfertilization (dpf), while quantitative real-time PCR (RT-PCR) analysis shows 
expression of αa1 does not surpass any other α-globin gene expression levels until 18 dpf [169].  
After knockdown of individual transcription factors, αa1 expression was assessed by ISH at 24 
hpf.  If loss of a factor resulted in the disruption of the process, it would indicate the gene is 
involved in its normal regulation.  By testing targeted, yet unbiased, genes by knockdown, we 
could potentially identify novel regulators of globin gene switching.  Screening for, and 
characterizing, these factors in the context of a whole organism will help facilitate the translation 
of the pathways to other system such as mice and potentially humans.  In addition, any genes 
identified would be potential repressors of adult globin expression, which could be useful during 
the erythroid differentiation of iPS and ES cells to promote an adult-like phenotype.          
Candidate genes to be assessed were identified through bioinformatic analysis of 
previously generated murine microarray datasets [216] comparing distinct stages of red cell 
development (Figure 3-1A).  Microarrays were performed on proerythroblasts, basophilic 
erythroblasts, orthochromatic/polychromatic erythroblasts, and reticulocytes isolated from 
murine yolk sac (YS), fetal liver (FL), and bone marrow (BM).  YS and BM represent distinct 
red cell populations with distinct globin gene expression profiles, separated by the intervening 
FL stage [7,171].  All differentiation stages harvested from the YS, FL, and BM were combined 
to generate the Primitive (P), Fetal (F) and Adult (A) sample sets respectively.  Pairwise 
comparison of these sets was performed and all differentially expressed genes identified.  Gene 
ontology (GO) terms were used to identify the transcription factors among the genes identified.  
An analysis of the expression pattern of these genes through the three stages (P, F and A) was 
performed by comparing the fold changes identified in the pairwise comparisons.  In order for a 
morpholino knockdown to more closely recapitulate the adult state and more likely induce adult  
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Figure 3-1. The combined knockdown of tcf7l2 and ncoa1 specifically increase adult globin 
expression in the embryo. 
(A) Schematic for generation of the candidate gene list.  The sample collection from mice and 
microarray were performed previously [216]. (B) Candidate genes tested by knockdown in the 
zebrafish.  Morpholino screen results for (C) single morpholinos and (D) morpholino pairs.  Each 
dot represents an individual embryo.  The sensitivity limit of the assay is 39 positive cells per 
embryo, and embryos with 40 cells or greater were classified and analyzed as having 40 cells. 
All morpholino and morpholino combinations were injected at 3 doses; absence of a dose 
indicates that the level of toxicity/death prevented analysis. All embryos directly compared are 
from the same, single-pair, clutch. *p<0.05, **p<0.01and ***p<0.001.  (E) ISH for αa1 in a 24 
hpf control and Tcf7l2/Ncoa1 double morphant embryo.  (F) Expression of tcf7l2 over 
developmental time.  All time points were normalized to the adult stage.  (G) Expression of 
ncoa1 over developmental time.  All time points were normalized to 17 dpf.  (H) Expression of 
globin genes in Tcf7l2/Ncoa1 double morphants (6 ng of each morpholino).  The sample was 
normalized to wild type, uninjected clutch control embryos.     
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Figure 3-1.  (Continued) 
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globin gene expression, representative transcription factors with lower expression levels in the 
adult state (e.g. reduced expression in A when compared to P and F) were further selected to 
generate a candidate gene list of 14 genes.  
As a whole genome duplication event occurred in the zebrafish evolutionary lineage 
[114], zebrafish often possess multiple orthologs to a mammalian gene.  The 14 mouse genes 
selected were found to have 17 orthologs in the zebrafish genome (Figure 3-1B).  Each gene was 
knocked down individually by morpholino and the number of αa1 expressing cells in the 
intermediate cell mass at 24 hpf was counted in each embryo.  Of the genes tested, four, hif1al, 
e2f5, ncoa1 and tcf7l2, significantly increased the number of αa1 expressing cells over control 
embryos (Figure 3-1C).  Pairwise knockdown of these four genes was then assessed.  Of the six 
pairwise combinations, ncoa1 with e2f5, tcf7l2 with e2f5 and tcf7l2 with ncoa1 produced greater 
increases in αa1 expression (Figure 3-1D).  The largest increase in the number of αa1 expressing 
cells was obtained with the combined knockdown of tcf7l2 and ncoa1.  Many embryos injected 
with the highest dose of morpholino (6ng of each), and some injected with the second highest 
dose (4ng of each), had more αa1 expressing cells than were readily countable (above 39 cells per 
embryo) and recorded and calculated as “40” (Figure 3-1D, E).  This significant increase 
demonstrates that both tcf7l2 and ncoa1 regulate globin gene expression.     
The expression of tcf7l2 and ncoa1 were also assessed in the zebrafish.  The expression 
of tcf7l2 is over 50 fold higher in 16 somite stage (s.s.) embryos than in adults, and its expression 
gradually decreased between these stages (Figure 3-1F).  In peripheral blood cells, expression is 
also approximately 1.5 fold higher in 16 dpf larva when compared to adult red cells (data not 
shown).  Ncoa1 expression was undetectable in most stages after 24 hpf, including larval and 
adult peripheral blood, but was over 14 fold higher in 16 s.s. embryos than 17 dpf larva (Figure 
 87 
 
3-1G).  Overall, these expression patterns indicate that tcf7l2 and ncoa1 are preferentially 
expressed in the developing embryo compared to the adult, which is consistent with both the 
microarray data from mouse erythroid cells and the role of these factors as repressors of adult 
globin.    
In order to determine the effect of this knockdown on the complete globin profile of the 
embryos, we performed RT-PCR on the double morphants for the globin genes.  As expected 
from the results obtained by ISH, the expression of αa1 increased, as compared to wildtype.  αa1 
expression increased over 19.5 fold, and the other major adult globin, βa1, increased over 16.5 
fold (Figure 3-1H).  The minor adult globin βa2 and larval globin genes βe2 and αe5 were also 
modestly increased at over 1.5 fold, 5 fold and 2.5 fold respectively.  The other embryonic/larval 
globins (αe1, αe3, and βe1) maintained similar expression levels to controls, and the embryonic 
globin βe3 was only increased by about 1.2 fold (Figure 3-1H).  This specific increase in the adult 
globin genes demonstrates that knockdown of tcf7l2 and ncoa1 is affecting the expression of 
specific globin genes and therefore globin switching rather than global globin or red cell 
functions.  While slight changes to the overall zebrafish morphology are observed at the highest 
doses of morpholino, significant increases in adult globin are observed at all combined doses, 
including those below which any obvious morphological disruptions were detected.  This 
indicates the morphological disruptions observed at higher doses are secondary to the phenotype 
or due to morpholino toxicity, and the increase is not an indirect affect of the morphological 
changes.             
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Identification of regulators of globin gene expression by a chemical screen 
A chemical screen was also performed to identify potential regulators of globin 
switching.  Embryos were collected, treated, and assessed using the same ISH assay utilized in 
the morpholino screen (Figure 3-2A).  Of the 3120 chemicals tested, 52 (~1.67%) were identified 
as preliminary hits that increase adult globin expression, while the remaining approximately 98% 
did not affect the number of αa1 expressing cells and/or substantially affected the morphology of 
the treated embryos.  One of the chemicals identified was L-thyroxine (Figure 3-2B).  L-
thyroxine (T4) is one form of thyroid hormone, and significantly increased the number of 
number of αa1 positive cells in a dose responsive manner, with many of the embryos treated at 
the highest dose exceeding the upper limit of the scale (Figure 3-2C).  The chemical XAV939, 
which was not included in the chemicals used in the screen, was identified in a supplemental 
screen carried out in the same manner.  XAV939, a tankyrase inhibitor that inhibits the Wnt 
pathway [236], also significantly increases adult globin expression in a dose responsive manner 
(Figure 3-2C).               
Tcf7l2 and ncoa1 act to regulate globin gene switching through the Wnt and thyroid 
hormone receptor pathways respectively 
With the identification of two pathways, Wnt and thyroid hormone, and two genes, tcf7l2 
and ncoa1, we wanted to determine the relationship(s) between these four elements.  As tcf7l2 
and ncoa1 are associated with the Wnt and thyroid hormone pathways respectively, we 
hypothesized that tcf7l2 regulates globin gene expression though the Wnt pathway and ncoa1 
regulates globin expression though the thyroid hormone pathway.   
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Figure 3-2. Activation of the thyroid hormone receptor pathway or inhibitor of the Wnt 
pathway leads to increase in adult globin expression in the embryo. 
(A) Schematic for the chemical screen. (B) αa1 in situ for a control and T4 treated embryo at 24 
hpf.  (C) Chemical treatment results for T4 and XAV939.  Each dot represents an individual 
embryo.  The sensitivity limit of the assay is 39 positive cells per embryo, and embryos with 40 
cells or greater subjectively categorized into six categories, which were classified and analyzed 
as “40”-“45.”  All embryos directly compared are from the same, single-pair, clutch. *p<0.05, 
**p<0.01and ***p<0.001. 
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Figure 3-2. (Continued) 
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As the combined knockdown of tcf7l2 and ncoa1 further increase adult globin expression 
in the embryo, substitution of XAV939 or T4 respectively should similarly work together.  As 
expected from the morpholino and chemical screen results, the knockdown of tcf7l2 and ncoa1 
individually increased the number of αa1 expressing cells, as did treatment with T4 and XAV939 
individually.  The Wnt pathway inhibitor XAV939 and knockdown of the thyroid hormone 
associated coregulator ncoa1 resulted in an additional increase in the number of αa1 expressing 
cells for the combined treatments of 10 μM/4 ng (Figure 3-3A).  An increase in the number of 
αa1 expressing cells was also observed for the thyroid hormone pathway agonist T4 and 
knockdown of the Wnt pathway transcription factor tcf7l2.  A number of dose combinations led 
to increases more significant than the corresponding doses of the individual agents.  For 
example, the combined dose of 1.0 µM of T4 and 6 ng of the tcf7l2 morpholino yielded an 
average of 40.11 αa1 positive cells per embryos, significantly more than the 20.82 and 11.88 
observed for single agents respectively (Figure 3-3B).  Similarly, co-treatment with XAV939 and 
T4 should produce a greater increase in the number of αa1 expressing cells.  This was also 
observed at a number of co-treatments doses, such as 10.0 µM XAV939 and 2.0 µM T4.  With 
this combined treatment, the average number of positive cells per embryos reached 33.91, 
significantly more than the 3.5 and 20.58 observed with the individual drugs (Figure 3-3C).  
Together, these results demonstrate that tcf7l2 and ncoa1 are functioning as members of the Wnt 
and thyroid hormone receptor pathways respectively in their role regulating globin switching.  
They also support that these pathways are functioning in parallel, and therefore can be modulated 
in conjunction to achieve greater changes in globin gene expression.    
The zebrafish thyroid hormone receptors, thraa, thrab, and thrb, were knocked down in 
control embryos as well as prior to T4 treatment.  Thraa and thrb are maternally deposited and  
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Figure 3-3. The regulation of globin gene expression by tcf7l2 and ncoa1 are through the 
canonical Wnt and thyroid hormone receptor pathways.  
Co-treatments with (A) Ncoa1 morpholino and XAV939, (B) Tcf7l2 morpholino and T4, (C) T4 
and XAV939, and (D) Thraa morpholino and T4.  Each column or row was treated with the 
listed morpholino or drug, and each box shows the average number of αa1 positive cells in the 
ICM at 24 hpf, using the scale that includes the categories 41-45. The background shade of the 
boxes reflects the average number of adult positive cells (the darker the higher).  Significance is 
indicated by the horizontal (purple) and vertical (orange) bars. *p<0.05, **p<0.01 and 
***p<0.001. 
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Figure 3-3.  (Continued) 
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expressed in the developing zebrafish embryo during the early treatment time window [237,238], 
so were potential candidates for transmitting the ligand signal into gene expression changes.  
Knockdown of Thraa blocked the induction of abnormal adult globin positive cells by T4 (Figure 
3-3D).  This result was confirmed with a second morpholino (data not shown).  This 
demonstrates that, as expected, T4 is signaling thought the thyroid hormone receptor, most likely 
Thraa, to modulate globin gene expression.   
The ability of both Wnt pathway modulators, XAV939 and tcf7l2, and both thyroid 
hormone pathway members, T4 and ncoa1, to function interchangeably in their ability to 
regulate globin gene expression clearly demonstrates that the genes identified are functioning 
thought the Wnt and thyroid hormone pathways to modulate globin gene expression.  Our studies 
confirm the roles of the thyroid hormone and Wnt pathways, both independently and in 
combination, in the modulation of adult globin gene expression.       
Activation of the thyroid hormone receptor pathway specifically increases adult globin 
gene expression  
In order to determine the effect of T4 treatment on the complete globin profile of 
embryos at 24 hpf, RT-PCR for the globin genes was performed.  All of the adult globins, 
including the expected increase in αa1, were increased over control (Figure 3-4A).  The largest 
increase was observed for βa1 (~19.5 fold), the second most for αa1 (~17.46 fold), and an 
approximately 4.5 fold increase was observed for the minor adult globin βa2.  The increase in αa1 
and βa1 was comparable to that observed in the double morphant (Tcf7l2/Ncoa1), but the 
increase in βa2 genes is substantially greater (compared to ~2 fold; Figure 3-1H).   The larval 
globin βe2 is also modestly increased compared to the control, but the larval α-globin αe5 is  
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Figure 3-4. T4 specifically increases adult globin gene expression. 
Expression of globin genes in T4 treated (A) 24 hpf embryos and (B) 16 dpf larva.  The sample 
was normalized to vehicle treated control embryos.  (C) In situ hybridization for red cell markers 
in wild type control, Tcf7l2/Ncoa1 double morphant, and T4 treated embryos at 24 hpf.  (D) All 
genes significantly altered (padj<0.1) in T4 treated (10 µM) 24 hpf embryos as assessed by 
RNA-seq.  Positive fold changes are increases and negative fold changes are decreases compared 
to vehicle treated control embryos.  
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Figure 3-4.  (Continued) 
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modestly decreased.  The embryonic/larval globins (αe1, αe3, and βe1) are slightly decreased 
compared to control.  The embryonic globin βe3 is increased by approximately 1.15 fold (Figure 
3-4A).  The preferential increase in adult globin genes, and even modest decrease in some 
embryonic/larval globins, strongly indicates a specific effect on the regulation of the endogenous 
globin switching process.       
Expression of the globin genes in zebrafish embryos begins at approximately the 12 
somite stage [30], so T4 treatments beginning at 50% epiboly can begin to affect globin 
expression prior to the establishment of the normal globin gene complement.  In order to test 
whether T4 treatment can disrupt a normal, established globin expression pattern, we treated 
zebrafish larval (15 dpf) and compared the globin expression to wild type controls (Figure 3-4B).  
While a similar pattern of increase is observed at 15 dpf as was at 24 hpf, the increase in αa1 
expression is greater (over 32 fold) and the increase in βa1 is less substantial (~13 fold).  In 
addition, a marked increase in the embryonic globin βe3 is also observed (Figure 3-4B), which is 
absent at 24 hpf (Figure 3-1H).  This demonstrates that T4 is able to not only establish an altered 
globin expression profile, but supersede an existing, established expression profile.  The ability 
to alter the globin expression profile of older embryos with larger numbers of red cells per 
embryo also facilitates further experiments.   
In order to determine if red cells were otherwise impacted by either T4 or tcf7l2 and 
ncoa1 knockdown, critical red cell markers were assessed by ISH and compared to wild type 
controls at 24 hpf.  The red cells specific genes alas2, band3, gata1, and mfrnI were all 
unaffected by either treatment shown to significantly alter globin expression (Figure 3-4C).  
Global expression changes resulting from T4 treatment were also assessed using RNA-Seq 
performed on treated 24 hpf embryos and vehicle treated controls.  A limited number of genes 
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were identified that are significantly altered by in vivo T4 treatment (5 upregulated; 16 
downregulated; Figure 3-4D).  The largest increase observed is an over 35 fold increase in αa1 
gene expression, an even greater fold increase than observed with T4 treatment at 24 hpf by RT-
PCR (Figure 3-4A).  The two next most significantly increased genes are the two minor adult 
globin genes with between approximately 4 and 10 fold increases (Figure 3-4D).  The largest 
fold decreases observed are in zgc:195209, a chemokine ligand (~56 fold decrease), sult5a1 
(sulfotransferase family 5A, member 1; ~27 fold decrease), and irg1l (immunoresponsive gene 1, 
like; ~11.5 fold decrease; Figure 3-4D).  It is also important to note that critical red cell 
regulators (i.e. gata1) and functional proteins (i.e. band3, alas2, mfrn1) were not identified as 
being misregulated by RNA-Seq (Figure 3-4D).  Together, these data indicate that red cells in T4 
treated embryos are healthy, functional, and present in normal numbers.  Additionally, the 
extremely limited number of genes altered indicates that T4 treatment may be inducing a 
targeted, direct response that does not require the transcription of additional genes to mediate an 
upregulation of adult globin gene expression.     
T4 treatment induces adult globin protein in a heterocellular manner 
The specific upregulation of adult globin, as observed thought ISH, RT-PCR, and RNA-
Seq, by T4 treatment demonstrates a clear increase in adult globin mRNA.  In order to 
demonstrate that activation of the thyroid hormone receptor pathway also leads to an increase in 
adult globin protein, a monoclonal antibody was developed specifically against adult zebrafish 
hemoglobin.  Embryos assayed at 24 hpf after T4 treatment did not express additional adult 
globin protein over control embryos (data not shown).  However, embryos treated at the same 
stage expressed substantially more adult globin protein than vehicle treated controls at 48 hpf 
(Figure 3-5A).  βe1 expression was also tested and appeared present and normal in both T4 and  
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Figure 3-5. T4 induces adult globin protein in a heterocellular manner. 
(A) Whole mount antibody staining for adult globin.  (B) Blood smear of larval peripheral blood 
stained for adult globin.  (C) Quantification of larval peripheral blood adult globin antibody 
stains.  The percent of positive cells was calculated using the number of adult globin positive 
cells and the total number of cells as determined by DAPI staining.  Each dot represents an 
individual larva.  **p<0.01.  (D) Analysis of costaining of adult globin and the embryonic/larval 
globin βe1.  Each bar represents the sample from one larva (“L*”) or the total for the group 
(“Total”).  Adult globin positive cells from each larva were identified and then assessed for 
larval globin status.  Each bar shows the percent of these adult globin positive cells that were 
larval globin negative (blue) and larval globin positive (red).   
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vehicle treated embryos at both 24 hpf and 48 hpf.  In order to quantify the increase in protein, 
15 dpf embryos were treated with T4 and lethally bled at 16 dpf.  The peripheral blood was 
fluorescently stained using the adult specific globin antibody, and the number of peripheral cells 
positive for adult globin was compared to the total number of cells and the percent of cells 
positive for adult globin were calculated for each embryo (Figure 3-5B).  The average percent of 
cells that were adult globin positive in the T4 treated embryos was 3.16% (n=10 embryos), 
significantly more than observed in the vehicle treated control (0.03%, n=8, p<0.01, Figure 3-
5C).  The ability to observe upregulation of adult globin in a subset of cells further supports the 
role of the thyroid hormone receptor pathway in the regulation of globin gene expression, and 
that no post-translational mechanisms prevent the translation of aberrant, T4-induced adult 
globin mRNA from being translated into protein.   
In order to determine whether the larval cells transcribing and translating adult globin 
mRNA and protein, respectively, which typically express almost excursively larval globins, also 
expressed larval globin, we co-stained with an antibody against the embryonic/larval globin βe1.  
We identified adult globin expressing cells isolated from T4 treated larva and determined 
whether they were co-positive for βe1.  Of the 193 adult globin positive cells observed from 10 
larva, 58.55% (113) were single-positive (Figure 3-5D).  In individual embryos with more than 
10 cells observed (n=7), the average percent of the cells that were single-positive was 61.48% 
(Figure 3-5D).  This demonstrates that the majority of T4 induced, adult globin protein 
expressing cells are not expressing the normal globin complement for their developmental stage 
in addition to adult globin.  These data demonstrates that, as expected, aberrant adult globin 
mRNA expression precedes aberrant adult globin protein expression, which becomes detectable 
approximately 24 hours after T4 treatment begins.   
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The thyroid hormone pathway regulates globin expression in adult zebrafish 
With the determination that the thyroid hormone receptor pathway regulates globin gene 
expression in the zebrafish embryo and larva, the role of the pathway in the adult context 
remained unclear.  We hypothesized that, as agonism of the pathway upregulates adult globin, 
antagonism of the pathway would increase the expression of larval, embryonic/larval, and/or 
embryonic globin genes.  The thyroid hormone receptor antagonist dronedarone (Dron) was used 
to inhibit thyroid hormone receptor function [239] in adult zebrafish.  Dron was injected once 
daily for 4 days retro-orbitally, followed by collection of peripheral blood and kidney marrow on 
the fifth day.  RT-PCR was used to assess the expression of the globin genes in Dron treated 
versus vehicle treated samples.  In peripheral blood, the embryonic globin βe3 was upregulated 
over 9.5 fold over control (Figure 3-6A).  The embryonic/larval and larval globin genes were 
also upregulated between 10 and 15 fold.  The major adult globins αa1 and βa1 were largely 
unaffected (Figure 3-6A).  In the kidney marrow, a similar pattern is observed, but with 
substantially larger increases.  The embryonic, embryonic/larval, and larval globins increase 
between 70 and ~800 fold and the adult globin genes increase between 9 and 18 fold (Figure 3-
6B).  These results show that inhibition of the thyroid hormone pathway results in the 
upregulation of embryonic and larval globin in the adult kidney marrow and peripheral blood.  
As modulation of this pathway in the embryo as well as the adult leads to changes in globin gene 
expression, the thyroid hormone receptor pathway must play a role in both the establishment and 
maintenance of adult globin expression at the mRNA level. 
Upregulation of larval globin expression at the protein level was assessed using 
fluorescent antibody staining against the embryonic/larval globin βe1.  After treatment with Dron, 
fish were individually bled and dissected to collect kidney marrow.  As with the assessment of  
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Figure 3-6. Thyroid hormone regulates globin gene expression in the adult.        
Expression of globin genes in dronedarone (Dron) treated (A) peripheral blood and (B) kidney 
marrow.  The samples were normalized to tissues from vehicle treated controls.  Quantification 
of larval globin positive cells in (C) peripheral blood and (D) kidney marrow or Dron treated 
adults.  The percent of positive cells was calculated using the number of larval globin positive 
cells and the total number of cells as determined by DAPI staining.  Each dot represents an 
individual. (E) Analysis of costaining of adult globin and the embryonic/larval globin βe1.  Each 
bar represents the cells from a single condition and tissue.  Larval globin positive cells from each 
adult were identified and then assessed for adult globin status.  Each bar shows the percent of 
these larval globin positive cells that were adult globin negative (blue) and adult globin positive 
(red).   
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Figure 3-6.  (Continued) 
 
 105 
 
the presence of adult globin protein in larval red cells, DAPI was used to determine the total 
number of cells present and the percent of βe1 positive cells was calculated for each animal.  The 
average percent of βe1 positive kidney marrow cells in the Dron group was 7.54%, more than the 
4.02% observed in the control group (Figure 3-6C).  Similarly, the peripheral blood from the 
animals in the Dron group had more βe1 positive cells on average than the control group (4.03% 
versus 0.71%; Figure 3-6D).  While neither increase is significant, this may be due to only a 
fraction of the individuals responding to the treatment, as the distribution in the treated groups is 
high, and/or the high level of variability of all samples.  These experiments are being repeated 
with larger numbers to determine if the increase is significant. 
Coexpression of adult globin protein was also assessed in these aberrant, thyroid 
hormone receptor antagonist induced cells.  Of the 27 βe1 positive cells observed in the untreated 
peripheral blood samples, 96.3% were also adult globin positive, as compared to 63.16% in the 
Dron treated samples (n=19; Figure 3-6E).  In the kidney marrow cells, the control cells were 
50% co-positive (n=48) while the Dron samples was 30.43% co-positive (n=69; Figure 3-6E).  
The expression of the embryonic/larval globin in the adult stage in the untreated group suggests 
that, analogous to mammalian F cells, erythroid cells expressing globin genes from earlier 
developmental stages persist into adulthood.   The higher percent of these βe1 expressing cells in 
the kidney marrow as compared to peripheral blood may suggest that less mature red cell 
progenitors may have a different globin expression pattern than peripheral blood.  The ability of 
Dron to increase the percent of βe1 positive cells in the kidney marrow to a greater degree than in 
the peripheral blood may due to this higher basal expression.  Induction of an embryonic/larval 
globin protein in the adult clearly demonstrates that the thyroid hormone pathway not only plays 
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a role in executing the normal developmental globin switching process, but also in the 
maintenance of the final, adult state.         
The thyroid hormone receptor pathway regulates globin gene expression in the mammalian 
system 
Both K562 cells, which express mainly fetal globin and a small amount of embryonic 
globin [81], and differentiating primary human fetal CD34+ cells were treated with T4.  As both 
cell types are analogous to the larval zebrafish globin state, we hypothesized that treatment 
would lead to an increase in adult globin expression as measured by adult β-globin.  An increase 
in β-globin was observed in both K562 and CD34+ cells after 24 and 72 hour treatments 
respectively (Figure 3-7).  The dose responsive increases in adult β-globin in K562 cells ranged 
from 12.5 to 18.5 fold while they ranged from 30.5 to 38.5 in differentiated CD34+ cells.  The 
embryonic and fetal β-like globins only increased by just over one up to two fold, but increased 
by between 1 and 14 fold in the CD34+ cells, with the largest increases observed for embryonic 
globin (Figure 3-7).  These results are comparable to or exceed those observed in whole 
zebrafish treatments (Figure 3-1H, 3-4A, B), demonstrating that the thyroid hormone pathway is 
both responsive in mammalian erythrocytes and regulates globin gene expression in a similar 
manner observed in the zebrafish system.           
Thyroid hormone receptor pathway members bind directly to globin loci 
The thyroid hormone receptor, its heterodimeric binding partner RXR, and its 
coregulators modulate gene expression through binding to DNA.  Therefore, we assessed their 
binding patterns in K562 cells.  In the α-globin locus, all three factors tested bind to the critical 
α-LCR DNase I hypersensitive site MCS-R3 while both Ncoa1 and RXRα bind to MCS-R1  
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Figure 3-7. T4 influences globin expression in mammalian cells.    
Expression of globin genes in T4 treated (A) K562 and (B) differentiated human fetal CD34+ 
cells.  The K562 cells were treated for one day and the CD34+ cells were treated for 3 days.  Four 
concentrations of T4 were used and are indicated by the bar shade.  The samples were 
normalized to vehicle treated controls. 
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Figure 3-7.  (Continued) 
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(Figure 3-8A).  In the β-globin locus, all three factors are bound to the critical LCR region HS 2.  
HS 4 is also bound by RXRα and TRβ, and 3’ HS1 is bound by Ncoa1 and TRβ (Figure 3-8B).  
The co-binding of these complexes to key conserved regulatory elements strongly indicates they 
may be functioning by acting directly on the globin locus.   
ChIP-seq analysis was also performed on zebrafish larval and adult peripheral blood.  
H3K27ac mark analysis was performed in cells from both states while RXRα ChIP-seq was 
performed only in adult cells.  In the major locus, regions of differential marking between the 
adult and larval samples were observed, with higher levels of H3K27ac associated with the 
region being actively transcribed in that cell type; higher levels on the adult globins in adult red 
cells and higher levels on the embryonic/larval globins in the larval red cells (Figure 3-8C).  The 
preferential histone marked region in adult cells encompasses both copies of the two major adult 
globins, αa1 and βa1, while the region enriched in larval cells covers all the embryonic/larval 
globin genes present on the locus except one copy of βe1.  The minor adult globins αa2 and βa2 are 
not located in either region of preferential H3K27ac marking.  RXRα binding was observed in 
adult red cells only within the adult specific region of differential H3K27ac.  Two distinct peaks 
are present, centered approximately between the transcriptional start sites of the two αa1/βa1 pairs, 
potentially indicating they are functioning by binding to the bidirectional promoters (Figure 3-
8C).  At the minor locus, which only encodes embryonic and embryonic/larval genes, only a 
region where H3K27ac was preferentially bound in larval red cells was observed (Figure 3-8D).  
The regions encompasses the larval globins αe5 and βe2, which have similar expression patterns 
[169].  Two distinct regions of RXRα binding were also observed in the minor locus.  One is 
located within the differentially marked H3K27ac region and between the transcriptional start 
sites of αe5 and βe2, indicating again that RXRα may be functioning through binding to the  
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Figure 3-8. Thyroid hormone receptor and associated factors bind directly to critical globin 
regulatory elements. 
Analysis of the binding of NCOA1, RXRα, and TRβ to the (A) α-globin and (B) β-globin loci in 
K562 cells.  DNase I hypersensitivity from the ENCODE Project is also shown in the bottom 
track [235].  The bars below each track indicates significant peaks where p<1e-07.  Shaded gray 
regions, and associated labels, indicate known regulatory regions.  All tracks are mapped to hg18 
and visualized using the UCSC genome browser (http://genome.ucsc.edu).  Analysis of the 
binding of RXRα in zebrafish adult peripheral blood and H3K27ac marks in adult and larval 
peripheral blood on the (C) major globin and (D) minor globin locus.  The bars below each track 
indicates significant peaks where p<1e-09.  Differential H3K27ac marking between adult and 
larval peripheral blood was determined and regions preferentially bound in adults (red) and 
larval (blue) are shown.  In some cases annotated genes were renamed in order to adhere to the 
naming convention, and in cases where a globin gene was not annotated, the UCSC BLAT tool 
was used to locate the ORFs included in the figure.  All tracks are mapped to Zv9 and visualized 
using the UCSC genome browser. 
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Figure 3-8.  (Continued)  
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Figure 3-8.  (Continued)  
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Figure 3-8.  (Continued)  
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bidirectional promoters of the globin genes.  The other RXRα peak is located upstream of αe4, in 
the region previously identified as the putative minor locus LCR (Figure 3-8D) [169].  These 
results indicate that critical hormone co-receptor RXRα, and that RXRα binding is associated 
with critical cis-regulatory regions.  Therefore the thyroid hormone receptor pathway may be 
acting directly at the globin loci to regulate globin switching.        
Discussion 
The study of hemoglobin switching has been critical to our understanding of general gene 
regulation.  Here we describe two screens, one knockdown and one chemical, that identify two 
pathways involved in globin gene regulation.  Down regulation of the Wnt pathway, with the use 
of Wnt inhibitors or by knockdown of the transcription factor tcf7l2, increased the expression of 
adult globin genes.  Activation of the thyroid hormone receptor pathway also promoted adult 
globin gene expression in the zebrafish embryo and in mammalian cell culture systems.  
Conversely, inhibition in the adult zebrafish system induced an embryonic/larval globin 
expression pattern.  Changes in globin protein levels were also induced by modulation of this 
pathway.   
The role of Wnt signaling in hematopoiesis has been extensively studied [9,140,142–
144,240], but its regulation of globin gene switching has not.  Here we demonstrate that the 
pathway does have a role in the erythroid process of globin gene expression.  While we 
demonstrate the pathway suppresses adult globin expression, further investigation is needed to 
fully determine its effects on globin gene switching and expression.   
Thyroid hormone was the strongest single agent inducer of adult globin gene expression 
in the embryo investigated in this study, and adult globin was also the most induced gene by 
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treatment (Figure 3-2, 3-4D).  The thyroid hormone receptor pathway is known to be involved in 
general development, and even the specific changes in globin gene expression that accompany it, 
since early work in frogs [91,157,241], with later work showing a direct role for the pathway 
[158].  The hormone is also known to regulate adult globin expression in the zebrafish embryo 
[242], but does not regulate globin gene switching in all organisms [243].  The globin regulating 
effect of the thyroid pathway had not been fully characterized nor its interaction with the Wnt 
pathway identified.  Importantly, implications of this effect were also not isolated from general 
metamorphic changes, extrapolated to the adult state, or translated to mammalian systems.   
Here, we demonstrate the ability of the thyroid hormone pathway to regulate both globin 
gene and protein expression outside of the context of metamorphosis.  By RNA-Seq analysis, a 
very limited set of genes is altered by T4 treatment (Figure 3-4D), indicating that, at the time 
points and/or doses used, full metamorphosis is not taking place.  The role of the thyroid 
hormone pathway in the maintenance of the adult globin state in addition to the establishment of 
it during metamorphosis, as demonstrated by the thyroid hormone receptor antagonist inducing 
embryonic/larval expression, also speaks to the pathway’s role beyond metamorphosis.  This is 
consistent with observed T3 levels in the zebrafish peaking during metamorphosis, but also 
remaining at a higher concentration in the adult than the early embryo [156].     
T4 treatment induced adult globin expression with expected kinetics.  With embryo 
treatment, mRNA is detectable at least as early as 24 hpf, but adult protein is not yet detectable.  
24 hours later, at 48 hpf, induced adult globin protein is clearly detectable (Figure 3-5A).  This 
protein induction, as well as the induction seen at the larval stage and in the adult stage (Figure 
3-5B, C, 3-6C, D), is critical to demonstrating that no additional layers of regulation restrict the 
effect of the thyroid hormone pathway after mRNA induction.  While we do not observe it 
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directly, we are able to infer that chain balance at the protein level, critical for producing 
functional hemoglobin, is not disrupted as we see the α- and β-globin genes being coordinately 
affected at the mRNA level (Figure 3-1H, 3-4A, B, 3-6A, B).  These results show that the thyroid 
hormone receptor pathway could potentially be modulated clinically without disrupting normal 
hemoglobin formation and the oxygen carrying function of red cells, which would be important 
for therapeutic applications.     
The co-expression of T4 induced adult globin expression potentially indicates a model 
where the globin genes are switching within an individual red cell.  Because we observe cells 
that are expressing both the normal globin and the induced globin, as well as cells expressing 
only the induced globin (Figure 3-5D), it is possible that the co-expressing state represents a 
transitional state.  This transition would be preceded by the single expression of the normal 
globin and followed by expression of the induced globin, all within the same cells.  This process 
would be akin to “maturational” globin switching rather than the cell replacement model 
typically seen in the normal larval to adult switching process [169].  Similarly, the presence of 
coexpressing normal adult globin and thyroid hormone pathway modulation induced 
embryonic/larval globin cells alongside side non-coexpressing cells of each type (Figure 3-6E) 
indicates an analogous process is likely occurring in the Dron treated adults.  In addition to also 
supporting the idea of a “within cell” transition, it also demonstrates that the adult state is not 
“locked” in.  While normal, endogenous processes, most likely involving the thyroid hormone 
pathway, allow the progress from embryonic, to larval, to adult globin, under normal conditions, 
a transition from the adult state to an embryonic or larval does not occur.  This would allow for 
the possibility that a “locked” cells state, epigenetic or other mechanisms, could exist that would 
not allow reversal of the process.  As we are able to achieve this reversal, it demonstrates this 
 117 
 
condition is not present and the model is malleable and ideal for studying this abnormal process.  
These transitions of globin genes within a single cell would be consistent with the model that the 
thyroid hormone receptor is binding to the globin locus and upstream enhancers to directly affect 
globin gene expression.  Utilizing T4 to induce adult globin expression in fetal-like cells is also 
advantageous to those attempting to generate mature, adult globin expressing erythrocytes from 
iPS or ES cells, which using current protocols often results in cells expressing embryonic or fetal 
globin genes [244].     
The identification and study of these pathways involved in hemoglobin switching using 
the zebrafish system also demonstrated the utility of the zebrafish as a model system for the 
study of this process.  The benefits of screening in the system are well documented 
[109,110,112,187], but the ability to translate findings to mammalian systems in the field of 
hemoglobin switching were not yet established.  Here, we demonstrate the conservation of these 
pathways from the mammalian system to the zebrafish embryo and adult systems.  This allows 
the study of this complex process in the context of a whole organism model more similar to, and 
malleable than, other whole organism (i.e. mice) models [169]. 
Clinical implications also exist for the use of thyroid hormone receptor antagonists in the 
treatment of hemoglobinopathies, such as sickle cell anemia.  Sickle cell disease is caused by a 
mutation in the adult β-globin gene that promotes polymerization of the translated protein, which 
in turn causes the distinctive sickling of the red cells and downstream disease symptoms.  
Increased levels of fetal hemoglobin ameliorate the symptoms of sickle cell disease by impeding 
polymerization, making pharmacological induction of fetal hemoglobin a logical mechanism to 
pursue for treatment of this disease [79,176,211].  In the zebrafish, we are able to induced fetal 
hemoglobin in the adult state with the thyroid hormone receptor antagonist dronedarone, a 
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United States Food and Drug Administration approved molecule for heart arrhythmia [245].  
While we were only able to achieve a modest increase in embryonic/larval hemoglobin in 
peripheral blood (Figure 3-6C), we did observe a larger numbers of positives cells in the kidney 
marrow (Figure 3-6D).  In addition, large fold increases of embryonic and larval globin mRNAs 
were observed in the kidney marrow (Figure 3-6B).  This may indicate that peripheral blood 
levels may rise further as these cells begin to enter circulation.  The short duration of the 
experiments (5 days) in conjunction with the relatively long half-life of red cells, approximately 
120 days in humans [246] and up to 270 days in carp [247], may mean treatment over a longer 
period, which would allow for additional red cell turnover, could increase the levels observed in 
peripheral blood, and make thyroid hormone receptor antagonists a viable potential treatments to 
pursue for sickle cell disease.  There is also limited evidence that, despite the feedback loops and 
other mechanisms regulating the human thyroid hormone axis, non-anemic hyper- and 
hypothyroid patients have abnormal globin expression profiles [248].  Continued study of these 
areas may open additional avenues for clinical investigation into pharmacological means to 
increase fetal hemoglobin by modulation of the Wnt and thyroid hormone receptor pathways.             
 
  
 
 
 
 
 
 
 
 
Chapter 4 
 
Discussion and future directions 
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Hemoglobin switching is a complex and tightly regulated developmental process.  
Mutations in the coding and non-coding, regulatory regions of the hemoglobin loci in humans 
directly lead to diseases ranging from mild to life-threatening.  The studies completed in this 
thesis aim to better understand the complex molecular coordination required for normal 
hemoglobin expression, switching, and overall function.  The zebrafish was characterized as a 
model for hemoglobin switching by annotating the globin loci, determining the full complement 
of globin genes expressed, and the developmental timing of the switches between these globins.  
The key regulatory element, the locus control region (LCR), for the major locus was also 
identified, allowing the generation of a red cell specific transgenics with a GFP reporter.  With 
the established standard for globin expression, it was then possible to screen for regulators of 
globin switching.  Both morpholino and chemical screens were undertaken, and the Wnt and 
thyroid hormone receptor pathways were identified as regulators of globin expression.  
Manipulation of these pathways can modulate globin protein expression in both the embryo and 
adult zebrafish.  Studies in two cell culture systems, differentiated human primary fetal CD34+ 
cells and the erythroid leukemia line K562, demonstrated that these pathways also regulate 
globin gene expression in mammals.  Through mechanistic studies carried out in both the 
zebrafish and human systems, the thyroid hormone receptor pathway is likely acting directly on 
the globin locus to influence gene expression.  This work has implications for furthering a better 
general understanding of hemoglobin switching and gene regulation, and, through this improved 
understanding, lay the foundation for better, more targeted treatments for some 
hemoglobinopathies.      
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Modeling Hemoglobin Switching in the Zebrafish 
Hemoglobin and hemoglobin switching have been studied since their first descriptions in 
1840 and 1934 respectively [20,59].  Significant progress in understand these topics has been 
made in the nearly 175 interceding years, many in conjunction with new models, and new 
techniques that can be used to study them.  The most common models currently used to 
investigate these topics vary from immortalized cells lines, primary cells from model organisms 
and humans, traditional model organisms, and transgenic systems.   
Human and murine cell lines such as the human erythroid leukemia line K562 and the 
murine erythroid leukemia line GM979 have been used to study this developmental process, but 
are often limited as they do not directly reflect the normal state of any naturally occurring cell 
state, nor interact in a proper cellular context.  The ability to obtain primary cells, such as human 
CD34+ cells, has allowed some in vitro studies to more directly investigate a normal cellular 
state.  However, once in culture, these cells also lack the normal interactions of their endogenous 
environment, and face technical limitations associate with primary cell cultures.  Whole model 
organisms, such as mice, allow these processes to be investigated in the correct context, although 
are not directly comparable to human systems. Most other non-primate species experience only 
one globin switch during development.  The fetal stage expression of γ-globin evolved more 
recently during primate evolution [98,249].  In the murine system, this distinction has been 
investigated and found, at least in part, to be driven by differential regulation and expression of 
the key globin regulatory protein BCL11A [64].  Practical and technical considerations also limit 
the use of these organisms for screening and studies of early developmental steps.  Transgenic 
systems, particularly the β-globin locus transgenic mouse [52], have been heavily, and 
successfully, used to study hemoglobin switching, but face many of the same practical and 
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technical limitations as non-transgenic models.  They also do not exactly recapitulate the human 
hemoglobin switching regulatory system as the murine environment results in the aberrant 
expression of the human genes [171].     
Characterizing the zebrafish as a model system 
The zebrafish system combines a number of advantages of whole organism, transgenic, 
and cell cultures systems.  The ability to quickly and efficiently screen by knockdown, 
chemically, or genetically in the context of a complete developing organism is ideal for 
investigating a complex developmental process.  However, in order to best utilize the system for 
the study of hemoglobin switching, the model needed to be better characterized and further 
developed.   
While hematopoiesis in the zebrafish, and even globin gene expression, had been studied 
in the fish, a detailed analysis of the genetic, epigenetic, temporal, and regulatory aspects had not 
been completed.  By assembling and annotating both the major and minor globin loci from BACs 
and other genomic assemblies, the complete set of globin genes present in the zebrafish was able 
to be identified.  In addition, many of proximal regulatory elements were identified as shared, bi-
directional promoters paired with an α- and a β-globin, suggesting a simple mechanism to 
maintain the proper, critical balance between α- and a β-chains.  While earlier work had 
demonstrated the presence of two globin loci in the zebrafish [124] and their arrangement in a 
“head-to-head” fashion separated by a bi-directional promoter [30,32], these features had only 
been identified for isolated pairs of globin genes, and did not map and annotate the structure of 
both loci.  The genomic and regulatory organization observed is distinct from that seen in 
mammal.  The mammalian system has two separate globin loci, genetically segregating the α- 
 123 
 
and β-like genes [38].  This arrangement implies an additional level of coordination between the 
loci to maintain chain balance that is unlikely to be present in the zebrafish system.   
To establish the temporal component of the hemoglobin switching process, a combination 
of in situ hybridization (ISH) and real-time quantitative PCR (RT-PCR) were used.  These 
methods corroborated each other to establish the normal, base line globin expression pattern.  
Establishing this pattern was essential in order to be able to evaluate perturbations.  The 
switching process begins with the onset of globin expression, switches twice, and completes 
around 32 dpf.  These results are roughly consistent with earlier work completed to determine the 
timeline of globin expression in the zebrafish including the stage of the onset of globin 
expression and the timing and location of the expression of different globin genes though 3 dpf 
[30].  However, in the adult stage, the results observed here differ from those in previous work.  
Through the analysis of cDNA libraries and HPLC for globin proteins, five major adult globin 
proteins were identified: two β-globin and three α-globin [32].  While this work also identifies 
two adult β-globins, the results would suggest a substantially larger percent of the total adult β-
globin to be composed of βa1 rather than βa2 based on the ratios observed in the mRNA 
expression.  While the expression ratio similarly favors βa1 at the protein level, βa2 contributes a 
higher percent of the total protein [32].  This could represent another layer of globin gene 
regulation, differential translation of mRNA species, or natural variation in techniques used.  The 
more striking difference observed is in α-globin expression.  Only a single α-globin species was 
found to contribute to the adult red cell population in this work compared to the three observed 
previously [32].  This discrepancy could be the result of posttranslational modifications altering 
the protein, the limitation of RT-PCR to detect all possible variations in cDNAs, or technical 
caveats leading to preparation related protein degradation.  Another potential explanation for the 
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observed variations could be presence of multiple haplotypes in lab strains of zebrafish.  Unlike 
laboratory mice strains, the zebrafish lines are not inbred and efforts were made to maintain 
genetic diversity within stock populations, so haplotype variations within a line are 
possible.  During the sequence analysis of PAC and BAC clones that were made from genomic 
DNA samples isolated from the same zebrafish line, SNPs and other variations were observed in 
the major globin locus. Almost all coding sequence variations were synonymous, but as we do 
not yet fully understand where all of the globin gene regulatory elements are and their 
functions, it is possible that non-coding mutations could have substantial differential effects on 
globin gene expression between individuals and families that inherit different hyplotypes of 
the globin locus in zebrafish stock populations (Yi Zhou, personal communication).  While this 
work clearly maps the globin loci and expression patterns of the globin gene mRNAs, further 
analysis at the protein level is needed to address this variation.   
Taken together, these results demonstrate the presence of two switches and three stages 
of globin expression analogues to those observed in humans, but the human switching process is 
completed between 10 and 11 months of development, substantial later than in zebrafish.  While 
in mice the process is completed between 13 and 14 days, only one switch occurs in the murine 
system [171].  The zebrafish provides an accelerated, two switch system to study the hemoglobin 
switching process.  In many cases changes to globin expression are correlated to changes in the 
location of erythropoiesis and the wave, primitive or definitive, of hematopoiesis [4,6,55].  This 
work, and previous analyses [30,32], generally support that model as the timing of the major 
globin switches coincide with the changes in location of erythropoiesis from the ICM, to the 
CHT, and finally to the adult kidney [27].  However, other variations in globin expression, 
particularly the shift in expression away from βe3, support a role for maturational globin 
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switching [26].  Therefore, it is likely that both cellular turnover and maturational globin 
switching contribute to the overall switching pattern observed during the development of the 
zebrafish.   
Understanding globin regulation in the zebrafish 
In addition to proximal promoters, globin genes are regulated by long-range enhancers in 
mammals, known as locus control regions (LCR).  These regions are characterized by critical 
DNase I hypersensitive sites and the binding of critical red cells transcription factors (e.g. 
GATA1).  In order to locate, characterize, and utilize an analogous region in the zebrafish, 
DNase I hypersensitivity and Gata1 ChIP-seq were performed.  A putative major locus LCR was 
determine bioinformatically and tested experimentally.  As the region was able to confer specific 
and robust reporter expression, it was characterized as the zebrafish major locus LCR.  However, 
the region does not contain sufficient information to result in proper, or any, switching behavior, 
even when combined with a native, temporally regulated zebrafish globin promoter.  This 
indicates the cis-regulatory elements sufficient for correct temporal control have not been 
completely elucidated.  In the mammalian system, the LCR, driving expression of a globin gene, 
is also sufficient to result in high levels of specific expression [35,37].  However, as observed 
here, normal developmental/temporal regulation is disrupted without the complete local 
organization found in the native locus [37,49,50,52].  The LCR discovered in the zebrafish is an 
α-LCR.  The major locus is syntenic with the human α-globin region, like other fish such as the 
puffer fish [34], and contains the conserved gene nprl3 (C16orf35) immediately upstream of the 
globin gene cluster.  As with the human α-LCR [42,99], the zebrafish major locus LCR is located 
within the introns of this gene.  This is consistent with the known evolution of the loci; the 
zebrafish loci diverged from mammalian precursor globin loci, before the divergence of the α 
 126 
 
and β clusters [33].  It is also consistent with the observed homology between the LCRs of other 
fish and humans [42].              
Screening in the zebrafish model 
With the establishment of the globin loci, the normal globin expression pattern, and the 
zebrafish major locus LCR, it was possible to take advantage of one of the most significant 
advantages of the zebrafish system: the ability to perform large scale screens on a whole 
organism.  The ability to generate a large number of optically clear, externally fertilized embryos 
quickly, and then easily assay temporal and spatial gene expression by in situ hybridization 
allows both chemical and knockdown screens to be performed in a high-throughput manner 
[109–112].  It is also possible, while in lower throughput manner, to utilize the adult zebrafish 
for analysis [113].   
Through accentuating the advantages and mitigating the disadvantages, and through the 
development of additional tools such as the LCR-GFP transgenic line and the zebrafish adult 
globin specific antibody, morpholino and chemical screens have been successfully completed.  
The success of these efforts demonstrates that the zebrafish, both the embryonic and adult 
systems, are appropriate systems for the productive study of hemoglobin switching.      
Thyroid Hormone and Wnt as Regulators of Hemoglobin Switching 
Identification of novel regulators of hemoglobin switching 
Once the zebrafish was established as a screening system for hemoglobin switching, two 
screens were designed to identify genes and pathways in its regulation.  A knockdown screen 
was designed using morpholinos injected at the one cell stage, with the embryos being assayed at 
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24 hpf.  This time point was selected to allow the maximum amount of time for the morpholinos 
to affect to globin gene expression prior to circulation beginning.  This would allow the easiest 
scoring of the embryos as all the red cells are located in the intermediate cell mass [27].  An 
increases in the adult globin gene αa1 was selected as the readout for the screen because: (1) the 
adult and larval globins have a low background level of expression at 24 hpf and small increases 
over a minimal base line are easier and more reliable to score compared to small increases or 
decreases in a highly expressed genes, such as the embryonic and embryonic/larval globins, (2) 
normal adult expression does not being until at least 17 dpf, leaving a large window to 
accommodate staging errors if they were to occur and would imply any observed change 
indicated an important alteration to globin regulation rather than a minor acceleration, and (3) αa1 
has a robust, reliable in situ probe for the detection of abnormal expression.  However, this 
approach does have limitations.  While the number of αa1 positive cells was able to be sensitively 
detected, the absolute changes in αa1 expression levels were not assessed, nor were the changes 
to any other globin genes.  This increased sensitively over RT-PCR, which would be used to 
detect changes in all globin, was most likely critical to detecting the changes observed in the 
knockdown screen as the initial phenotypes observed were subtle.  While chemical screening is 
extremely high-throughput, there are practical limitations for morpholino based knockdown 
screens.  In order to generate a candidate gene list enriched for potential regulators of globin 
switching, data from murine microarrays on erythroid cells were utilized.  The hypothesis was 
that transcription factors regulating globin changes would be differentially expressed in cells 
expressing different globins.  Furthermore, as factors would be knocked down in embryos and 
adult globin would be assessed, factors were identified that would more likely generate this 
phenotype; factors that were over expressed in the fetal, adult, or fetal and adult stages compared 
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to the embryonic state were selected.  Mouse cells and microarrays were utilized as sufficient 
markers are not available to separate all of the desired cells types in the zebrafish system.  This 
introduced additional potential for cross-species difference to affect the validity of the screen.   
After generation of the candidate gene list, completion of the knockdown screen, and 
completion of the chemical screen, four genes and number of chemicals had been identified.  In 
order to determine which pathways to investigate further, the results of both efforts were 
compared.  The largest increase observed in the knockdown screen was the combination of tcf7l2 
and ncoa1 knockdown.  As these are associated with the Wnt and nuclear hormone receptor 
pathways respectively, and two significant results from the chemical treatments were XAV939 
and T4, representing the Wnt and thyroid hormone receptor pathway, a member of the nuclear 
hormone receptor superfamily [146], respectively, these two pathways were pursued.  
Specifically, T4 treatment was the most substantial single agent inducer of adult globin, so was 
further selected for additional testing.      
Monoclonal antibody development 
While the zebrafish model was well characterized during the course of this work, tools to 
assess protein expression were still limited.  HPLC and mass spectroscopy have been utilized to 
assess zebrafish globin expression at the protein level [30,32], but are limited for assessing 
protein expression and co-expression at the cellular and whole-mount level.  An antibody against 
βe1, an embryonic/larval globin, is commercially available (Anti-Hbbe-1.1 (NT), Z-Fish; Catalog 
#55608, Anaspec, Fremont, CA), but no zebrafish adult globin specific antibody is available.  An 
adult globin specific antibody was developed in conjunction with the Dana-Farber Cancer 
Institute Monoclonal Antibody Core (Boston, MA) by immunizing mice with purified adult 
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zebrafish red cell lysate.  As peripheral blood is predominantly red cells and globin is the 
predominant protein produced by red cells, peripheral blood was collected from adult fish, lysed, 
and membrane fragments removed by ultracentrifugation.  After multiple rounds of boosting, 
spleen cells were collected and fused to form hybridomas.  Clones were screened using a 
combination of western blotting and blood smear antibody staining to select a clone specific to 
adult globin.  Whole protein rather than a peptide fragment was used for immunization in order 
to increase the likelihood that the antibody would work on protein in the native confirmation, 
such as in blood smears and whole-mount staining.  With the development of this additional tool, 
it facilitates future globin expression studies in the zebrafish as embryonic and adult globins can 
now be detected and distinguished at the mRNA and protein levels.      
Role of Wnt in adult globin expression 
Inhibition of the Wnt pathway, with the inhibitor XAV939 or by knocking down tcf7l2, 
in the embryo leads to an increase in adult globin expression.  These results indicate that Wnt is 
involved in the maintenance of the embryonic state, or potentially that the absence of a Wnt 
signal in the blood at this time triggers the activation of another signaling pathway that promotes 
the adult globin state.  There is no known role of tcf7l2 or Wnt directly in hemoglobin switching, 
but the pathway is integrally involved in hematopoiesis [140,143–145], increasing the likelihood 
that such a role would exist.   
Role of thyroid hormone in embryo-to-adult globin switching 
Activation of the thyroid hormone receptor pathway with T4 treatment increases adult 
globin expression in the embryo.  This finding is consistent with the literature on the role of T4 
in the induction of metamorphosis [155,215], and even the direct role of hemoglobin switching 
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in amphibians [250].  The direct role observed in amphibians was demonstrated by the addition 
of T3 to tadpoles followed by assessment of the expression of both tadpole (embryonic/larval) 
and frog (adult) globin genes.  The expression of frog globin is induced by T3, but in never in the 
same cells as tadpole globin, similar to the coexistence of distinct tadpole globin expressing and 
frog globin expressing cells observed during natural metamorphosis.  This, and additional 
experiments, indicate that in the amphibian system T3 induces frog globin expression in 
progenitor cells that undergo DNA replication prior to the onset of globin expression [250].  The 
upregulation of adult globin with T4 treatment in zebrafish has also been reported as part of a 
microarray study on the effects of bisphenol A in the environment [242], but the implications for 
hemoglobin switching have not been investigated.  The ability to increase the amount of both 
adult globin mRNA and protein in embryos and larva is critical, as it  demonstrates that the 
effects of the thyroid hormone pathway is not limited in inducing adult globin that can be 
incorporated into functional adult hemoglobin.  The effects of the pathway would be less 
interesting if it induced only mRNA and not protein.  The induction of mRNA, as observed by in 
situ hybridization, occurs in a short period of time, approximately 19 hours between the initiation 
of T4 treatment at 50% epiboly and the assay at 24 hpf.  Induced adult globin protein is not 
detectable at this stage (24 hpf), but is detectable by 48 hpf.  When treating larva, induced adult 
globin positive cells were detectable 24 hours after the initiation of T4 treatment (15 dpf-16 dpf).  
Together these data indicate that T4 is able to induce adult globin mRNA in under 24 hours, with 
protein beginning to appear in approximately 24 hours.  When this induced adult globin protein 
is detected, it can be detected in some cells that are also expressing the embryonic/larval globin 
βe1.  One potential explanation for this observation is that cells already expressing 
embryonic/larval globins are being induced to express adult globin and transitioning thought the 
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co-expressing state observed.  This observation is in contrast that that observed in amphibians, 
where thyroid hormone induced frog globin is not co-expressed in the same cell as tadpole 
globin [250].  This would imply that the cell type that is affected is already expressing 
embryonic globin and not an early progenitor, but further study is needed to determine the target 
cell type(s) as well as the true nature of the co-expressing cells.  The interactions between the 
two pathways identified that induce adult globin expression in the embryo, the thyroid hormone 
receptor and Wnt pathways, have been characterized [165–168], but not in relation to 
hemoglobin switching.  Further study is needed to better characterize this relationship in this 
context to develop a more complete picture of hemoglobin switching regulation 
Role of thyroid hormone in adult-to-embryonic/larval globin switching 
Inhibition of the thyroid hormone receptor pathway with dronedarone treatment increases 
embryonic and larval globin expression in adult peripheral blood and kidney marrow.  This result 
implies that the thyroid hormone receptor pathway is involved in the maintenance of the adult 
globin state in addition to its establishment.  Similar to the co-expression of embryonic/larval 
and induced adult globin in the embryo and larval, a number of adult cells co-express adult 
globin and induced embryonic/larval globin, βe1.  This many imply the existence of a transitional 
state and implicate a globin expressing cell type as the target of globin modulating thyroid 
hormone receptor signaling.  This ability to modulate thyroid hormone receptor signaling to 
induce embryonic and/or larval globin is particularly interesting as it may have implications for 
the clinical treatment of some hemoglobinopathies [176].        
Role of thyroid hormone in mammalian globin switching 
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T4 treatment of fetal globin expressing K562 cells and differentiated primary human fetal 
CD34+ cells increases adult β-globin expression.  While it has been speculated that there is 
conservation of a metamorphosis-like process in amniotes, including mammals [159], the thyroid 
hormone receptor pathway has not been observed to regulate globin switching.  This link, while 
still currently limited to cell culture experiments, is critical as it demonstrates that the 
observations made in zebrafish, a system that does undergo traditional metamorphosis, are still 
valid in a non-metamorphosing mammalian species.  This not only provides support for the 
continuation of this line of work, but also further justifies the zebrafish system for the study of 
hemoglobin switching.  The evidence these systems provide to show that the thyroid hormone 
receptor pathway may act directly on the globin locus is also critical.  While the thyroid hormone 
receptor pathway can have numerous secondary effects in various tissue types, a direct, ligand 
induced effect mediated though a receptor directly bound to a target gene would be consistent 
with known thyroid hormone receptor functions in other tissues and systems [150].  As the 
regulation of globin switching is multilayered and complex, identifying a pathway that may be 
direct could: (1) allow for an increased effect as fewer other pathways can compensate and (2) 
limit off target effects, at least within the target cell type.  While the data presented here still 
allow for a few potential models of this direct interaction, one model would restrict the role of T4 
bound to TR an NCOA factor to inducing adult globin expression and invoke another, yet 
unidentified, nuclear hormone receptor pathway to promote embryonic globin expression in the 
embryo (Figure 4-1A).  Another model would be that TR directly regulates both embryonic and 
adult globin expression, with the embryonic globins being a negative target and the adult globins 
being appositive target (Figure 4-1B).  However, the thyroid hormone axis in humans is itself 
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Figure 4-1. Models of thyroid hormone receptor action on globin loci. 
(A) In the embryonic state, embryonic globin genes are activated by a yet unidentified nuclear 
hormone receptor complex containing an Ncoa factor, and adult gene transcription is 
repressed/not activated by a TR complex containing an Ncor factor.  In the adult state, T4 is 
present and the ligand for the unidentified nuclear hormone receptor is not.  Gene transcription of 
the adult globin genes is activated by a TR complex containing an Ncoa factor, and embryonic 
globin transcription is repressed/not activated by a complex containing an Ncor factor. (B) In the 
embryonic state, embryonic globin genes are activated by a TR complex containing an Ncor 
factors, and adult globin gene transcription is repressed/not activated by a TR complex 
containing and Ncor factor.  In the adult state, T4 is present and gene transcription of the adult 
globin genes is activated by a TR complex containing Ncoa, and the embryonic globins genes are 
repressed/not activated by a TR complex containing an Ncoa factors. (Ncoa – any member of the 
nuclear hormone receptor coactivator family; Ncor – any member of the nuclear hormone 
receptor corepressor family; NHR – a yet unidentified nuclear hormone receptor; TR – either 
thyroid hormone receptor; RXR – any member of the retinoid X receptor family; T4 – thyroid 
hormone; purple hexagon – ligand for the yet unidentified nuclear hormone receptor) 
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Figure 4-1.  (Continued) 
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complicated, regulated by feedback loops, and can have major systemic effects, so may not be an 
ideal therapeutic target.  
Clinical implications for hemoglobinopathies   
With the evidence that the thyroid hormone pathway both establishes and maintains the 
adult-like globin state in zebrafish, and that the function of this pathway may be conserved in 
mammalian cells, it possible that the thyroid hormone receptor pathway is also involved in the 
maintenance of the adult pathway in humans.  This would imply that inhibition of the pathway 
would induce embryonic and/or fetal hemoglobin production in hemoglobinopathy patients, 
ameliorating some symptoms.  Differences in thyroid hormone levels have been correlated to the 
expression levels of particular hemoglobin genes in humans [248], but further testing is needed 
to better characterize and quantify these correlations, particularly directly in patient populations.  
In addition, the number of embryonic globin positive cells induced with dronedarone treatment is 
low compared to what would be required to achieve a clinical effect [176].  However, the short 
treatment window, retro-orbital route of administration, cross-species differences and other 
factors could contribute to a lower level observed in zebrafish than could be obtained in patients.  
In addition, the molecule, exact target in the pathway, or treatment cocktail could be optimized 
for use in humans.  It is unlikely manipulation of the global thyroid system would be a safe, 
effective method of eliciting such a specific response.  This work demonstrates that targeting 
specific factors in the pathway, such as Ncoa1 or only one of the thyroid hormone receptors, 
maybe a more targeted way to maximize the desired response while minimizing the off target 
effects.  It may also be possible to specifically target erythroid cells in order to limit systemic 
effects by treating cells ex vivo or utilizing antibody targeting technologies [251].  While the 
thyroid hormone pathway may not be an ideal target for pharmaceutical treatment of the 
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hemoglobinopathies at this time, and substantial additional work in model systems, and humans, 
will be needed, the data presented here support further investigation into its therapeutic potential.               
Future of Hemoglobin Switching Research in the Zebrafish 
Identification of additional new regulators 
With the characterization of the zebrafish as a model for hemoglobin switching complete 
and the success of the morpholino knockdown and chemical screens, these data demonstrate that 
the zebrafish is an ideal model for identifying and studying regulators of globin gene expression.  
A natural extension of this work would be the completion of an overexpression screen.  The 
knockdown screen completed in this thesis utilized candidate genes generated from the analysis 
of microarrays data on mouse red cell samples collected form yolk sac, fetal liver, and adults.  
These samples express different globin genes, and therefore, potentially, differentially express 
globin gene regulators.  During the process of identifying candidate genes for the knockdown 
screen, genes for which a knockdown in the embryo would result in a state more closely 
resembling that of the adult were selected.  The remaining genes, those for which overexpression 
would result in a state more closely resembling that of the adult, have therefore already been 
identified.  This list is therefore likely to be enriched for regulators of globin gene expression as 
the list examined in this work yielded a high percentage of “hits” (~23%).  The list of candidate 
genes to overexpress also contains known critical regulators of globin switching bcl11a and 
sox6, which function together to act as suppressors of fetal hemoglobin in mammals [63–65], 
consistent with overexpression in an embryo leading to increased levels of adult globin 
expression.  In addition, preliminary data in the zebrafish shows that overexpress of bcl11a does 
in fact lead to a significant increase in the number of α-globin mRNA positive cells in the 
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embryo at 24 hpf (Janelle Lambert, appendix).  While overexpression screens are typically more 
difficult to establish, execute, and interpret than knockdown screens, they have been completed 
successfully in zebrafish [113].  In addition to having already generated an enriched candidate 
gene list, there are also a number of tools now in place to expedite such a screen.  First, a new 
Gateway recombination cloning technology (Life Technologies, Grand Island, NY) destination 
vector was generated.  This vector contains the draculin (drl) promoter, which drives expression 
in the mesoderm, including red cells (Christian Mosimann, manuscript in submission), driving 
the expression of GFP as a reporter in addition to the standard recombination sites used to easily 
clone in a desired promoter/gene of interest combination.  This vector with an additional, smaller 
drl promoter driving another reporter gene has been successfully cloned and expressed in 
zebrafish (data not shown).  Use of this reporter would aid a screener in identifying and selecting 
successfully injected embryos, which has been critical in similar screen [113].  An improved 
potential screening assay could also be used in place of in situ hybridization.  Now that an 
approximate time line has been established for induced globin protein expression (just over 24 
hours), whole mount fluorescent antibody staining using the newly developed adult globin 
specific antibody could be utilized to assay for changes in protein expression.  While in situ 
hybridization was successfully used in this work, whole mount antibody staining is a faster, more 
robust protocol, and throughput could be increased by utilizing it.  Also, the screen would 
directly read-out genes that result in changes to protein levels, which is critical for follow up 
investigations.  The scoring system used in this work, in addition to the tools developed to assay 
and quantify the results, could also be adapted to an overexpression screen, reducing the need to 
completely redevelop these aspects.  Similarly, the presence of a positive control, identified in 
this work, could allow for expedited screen development and more accurate results.  Such an 
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overexpression screen might also have an advantage over a knockdown screen; translation to 
increasing fetal hemoglobin in human patients may be more straightforward, as pharmaceutical 
inhibition of targets is typically more common than activation. 
New technology developed since the initiation of this work, the CRISPR-Cas system, 
could also be utilized to screen for additional regulators of hemoglobin switching.  The system 
utilizes a bacterial derived nuclease and guide system to generate genomic mutations and 
deletions in zebrafish and other systems [252–256].  Once genes were knocked out, the 
phenotype at each developmental stage could be evaluated, whereas morpholinos are limited to 
only early stages.  In addition, the knockdown would be complete and able to be verified by 
PCR.  However, this could also limit the analysis of essential genes as different doses of the 
target cannot be achieved.                                      
Further characterization of the role of the Wnt pathway 
In addition to identifying new pathways, the role the Wnt pathway plays in globin gene 
regulation could be further characterized.  This work is the first time that Wnt has been shown to 
be involved in the regulation of globin gene expression, but does not identify the mechanism 
though which this regulation occurs.  In order to determine the mechanism, ChIP-seq, RNA-seq, 
and knockdown experiments could be performed, similar to those used to elucidate a better 
mechanistic understanding of the thyroid hormone receptor pathway.  As was initially 
determined in the knockdown screen, tcf7l2 is involved in the regulation of globin gene 
expression, which can focus the initial investigation of the Wnt pathway.  As a phenotype has 
been observed in both K562 and primary CD34+ cells, ChIP-seq for TCF7L2 could be performed 
in these cell types.  In K562 cells, the binding patterned could be observed and compared 
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between untreated, γ-globin expressing cells and T4 treated cells expressing higher levels of β-
globin.  The effect of XAV939 in cell culture could also be examined and, if a phenotype is 
observed, used as another comparison condition for ChIP-seq experiments.  In CD34+ cells, fetal 
and adult cells could be compared to determine if normal developmental differences exist for 
TCF7L2 binding as the globin genes change.  Similarly, the various drug combinations could be 
compared to determine how binding patterns change under conditions that alter globin gene 
expression patterns.  These conditions could also be compared using RNA-seq to determine 
which, if any, genes are altered.  This would help to determine whether the Wnt pathway is 
acting directly on the globin locus or if it regulates the expression of other genes known to 
regulate globin gene expression.  The result of these RNA-seq experiments could be combined 
with other information known about the functioning of the Wnt pathway, such as the roles of β-
catenin, to perform knockdown/knockout experiments, either in zebrafish or cell culture, to 
determine which aspects of the Wnt pathway are responsible for its role in globin gene 
expression.  These experiments could be aided by tools such as the zebrafish Wnt reporter line 
[257] and the CRISPR-Cas system for zebrafish [254] and human cells [252,253,255,256].        
Once the role of the Wnt pathway is better understood, its interaction with the thyroid 
hormone receptor pathway could also be further examined.  As critical factors are determined 
from the studies above and correlated with data gathered from this investigation of the thyroid 
hormone receptor pathway, co-immunoprecipitation experiments could be performed to 
determine if direct interactions between these pathways exist and are altered as changes in globin 
expression occur, either as the results of normal development or experimental manipulation.  The 
results of the ChIP-seq and RNA-seq experiments above could be further examined to determine 
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if critical Wnt factors are binding to, and/or altering the transcription of, critical thyroid hormone 
receptor pathway members.      
The role of the Wnt pathway in adult globin expressing states could also be further 
examined.  The adult globin inducing role of T4 was identified in embryos, but further 
investigation demonstrated that inhibition of the pathway induced embryonic/larval globin 
expression in adults.  Therefore, it is possible that, as inhibition of the Wnt pathway in embryos 
induces adult globin, activation of the Wnt pathway in adults would induce embryonic and/or 
larval globin expression.  A Wnt activator such as BIO [258] that has been successfully used in 
zebrafish [145] could be injected retro-orbitally into adult zebrafish and the globin mRNA 
expression determined by RT-PCR and protein changes assessed with fluorescent antibody 
staining, analogous to the experiments completed for dronedarone here.  The requirement of the 
Wnt pathway for the development and regeneration of the hematopoietic system, but its 
expendability for adult steady-state function [145], may indicate that the Wnt pathway generally 
promotes the embryonic-like state.  It has been recently shown that the Wnt pathway, though 
TCF7L2 (the same factor identified here), reinforces lineage-specific regulators though direct 
binding of the factor to the same regions of the DNA, which then enhances expression and 
repression of the genes already targeted by the lineage regulator [145].  This is consistent with 
our results where knockdown of the Wnt pathway promotes an adult-like state. It suggests a 
model where loss of reinforcement of the embryonic state, loss of Wnt, allows lineage, and 
potentially stage, specific factors to have reduced influence and potentially allow “leakage” of 
incorrect gene expression.  This would also be consistent with the low level induction observed 
with the Wnt inhibitors.  This model could be used to further probe the role of the Wnt pathway 
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in globin gene regulation and potentially the distinction between the embryonic and adult states 
more generally.     
As potential interactions between these two pathways could also exist in their role in 
promoting embryonic and/or fetal globin induction, they could be investigated using similar 
approaches as above.  These interactions could be potentially advantageous for use in the clinic 
as a relatively large induction of fetal hemoglobin is needed to achieve a therapeutic threshold 
[176], and this could possibly be more easily achieved with a combination of agents from the 
Wnt and thyroid hormone receptor pathways.     
Further mechanistic analysis of the thyroid hormone receptor pathway 
While this work provides evidence to support the role of the thyroid hormone receptor 
pathway in the regulation of globin switching by direct action at the globin locus, further study is 
still needed to fully understand its role.  The thyroid hormone receptors act in coordination with 
a number of heterodimeric partners, members of the RXR family, and coregulators, members of 
the Ncoa and Ncor families [150].  Ncoa1 was initially identified in the knockdown screen 
performed here as suppressor of adult globin in the embryo.  However, the exact role of the 
coregulator remains undetermined.  In order to better assess the exact mechanism of the 
individual members of this pathway, it would be necessary to enrich for the affected cell 
population.  As only a small fraction of the cells treated with either T4 or dronedarone alter their 
globin expression profile, assessment of the entire cell population will likely mask any changes 
occurring in the affected cells.  However, due to technical limitations at this time, it is not 
possible to generate sufficient numbers of, or isolate and selectively interrogate, these cells.  If 
this technical hurdle can be overcome, the role of the individual pathway members could be 
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elucidated though a combination of expression, protein interaction and ChIP-seq experiments.  
The expression status and level of each member of the pathway could be determined in induced 
embryonic, those expressing adult globin, and induced adult, those expressing embryonic globin, 
cells and compared to their untreated counterparts.  This would set the landscape of which 
factors could be playing a role in the process, and provide potential hints as to which factors 
were important if significant expression changes were observed.  The various complexes the 
factors form in the four conditions could be assessed using protein mass spectrometry, indicating 
which factors changes as a result of treatment.  Finally, ChIP-seq experiments could be 
performed to verify the binding of these factors to known globin regulatory sites, implicating the 
alteration of certain proteins and protein complexes in the direct regulation of globin expression.  
Interactions with known regulators 
Neither the Wnt nor thyroid hormone receptor pathways are the only known regulators of 
globin switching.  The interactions between these known pathways and regulators is essential to 
fully understanding the developmental process as well as more successfully pharmaceutically 
targeting one or more aspects for the treatment of hemoglobinopathies.  The BCL11A pathway 
has emerged as a key repressor of fetal hemoglobin in humans and as a target for clinical 
modulation of globin expression [63,64,79].  The role of Bcl11a in globin switching has been 
investigated in zebrafish and exhibits similar functions in regulating globin switching as in other 
systems (Janelle Lambert, appendix).  As the reagents and tools to interrogate this pathway exist 
in the zebrafish, including Bcl11a overexpression constructs, morpholinos for knockdown, and a 
genetic mutant from the Welcome Trust Sanger Institute [259] that exhibits a globin expression 
phenotype (David Wiley, personal communication), studies to determine the relationship 
between the Bcl11a pathway and the thyroid hormone receptor pathway could be studied in 
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zebrafish embryos and adults.  By treating embryos with T4 and overexpressing Bcl11a, both of 
which increase the expression of adult globin, any additive, antagonistic, or synergistic effects 
could be assessed by RT-PCR and fluorescent antibody staining.  This experiment would help to 
determine if and/or how these pathways work together.  Conversely, embryos could be treated 
with combinations such as: (1) the Bcl11a morpholino and T4, (2) overexpressing Bcl11a and 
treating with dronedarone, and (3) the Bcl11a, Tcf7l2 and Ncoa1 morpholinos.  Assessing the 
results of the opposing effects of these treatment pairs would help to begin to establish and 
define the epistasis interactions between these agents and pathways.  Similarly, bcl11a mutant 
adult zebrafish could be treated with dronedarone, both of which should increase 
embryonic/larval globin expression, and the resulting combined effect assessed for additive, 
antagonistic, and synergistic effects.  Additional combinations such as: (1) bcl11a mutants 
treated with T4 and (2) Bcl11a overexpressing fish treated with dronedarone, could be used to 
assess the epistatic relationships in the adult setting.  Interesting results from these investigations 
could then be further expanded to include factors directly linked to the function of Bcl11a in its 
role as a regulator of hemoglobin switching, such as Sox6 [65].  These studies could also be 
expanded to include the interactions and epistatic interactions between the Wnt and Bcll1a 
pathways.  Together, this work would aid in putting the data and observations made here into the 
broader context of the hemoglobin switching landscape, which could also further any potential 
goals of achieving clinical benefit for patients. 
Assessment of genomic configuration 
Looping of DNA from the locus control region (LCR) into physical interaction with the 
proximal globin gene promoters is a critical step in the regulation of globin expression by this 
essential enhancer of the region, and chromosome conformation capture techniques have been 
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invaluable in better understanding these physical interactions that regulate gene expression [35].  
As the breath and variety of these techniques continues to expand, they can contribute even more 
to the general understanding of gene regulation, particularly at the globin locus [260].  As critical 
DNA elements have now been defined, with nearly base pair resolution, such as the major locus 
LCR and proximal globin promoters, these techniques are now feasible for use in the zebrafish to 
better understand both normal, developmental globin gene switching as well as thyroid hormone, 
Wnt, and Bcl11a pathway induced globin gene expression changes.  These techniques can 
identify disparate regions of DNA that enter into close physical proximity to exhort regulatory 
control, as well as help to identify protein factors that cause, enhance, or otherwise promote these 
regulatory effects [260].  Incorporating an understanding of the physical interactions of the 
chromosome and the proteins that control them will significantly contribute to a better 
understanding of the globin switching process and role of pathways such as the thyroid hormone 
receptor pathway in these changes.              
Interaction with mutants 
One of the many advantages of the zebrafish system is the availability of a large number 
of mutants with hematological phenotypes [28,119].  These mutants can be used to help further 
characterize the globin gene expression phenotypes observed with modulation of the identified 
pathways.  For example, the zinfandel mutant has a hypochromic microcytic anemia, but only 
during the embryonic stage [30].  As the phenotype of these mutants is correlated with the 
developmental stage of the erythrocytes, treatment of embryos with T4 or adults with 
dronedarone could yield results that would further support that the globin locus is specifically 
being altered by the thyroid hormone modulation, or that the entire state of the cell is being 
altered.  As it is believed that the zinfandel mutation is located in a regulatory site upstream of 
 145 
 
the major globin locus (data not shown, Yi Zhou, personal communication), further investigation 
of these pathways in this system could also help to establish which binding events these 
pathways alter are functional, and the particular function of individual binding sites.               
Murine systems and clinical translation 
While there are a large number of reasons why the zebrafish is an ideal system to study 
hemoglobin switching and cell culture models may be helpful in extrapolating the findings to 
other systems and opening up additional tool boxes, they have limitations when translating 
potential treatments to the clinic.  In order to further investigate T4 modulation as a potential 
therapy, additional studies need to be completed in the murine system.  However, mice have a 
single globin gene switch rather than the two observed in humans and zebrafish. Mice containing 
and expressing the entire human β-globin region in a developmentally regulated manner have 
been developed to study human globin regulation in a whole model organism [52].  This study 
has already shown that modulation of this pathway can alter globin gene expression in a 
mammalian system, but follow up studies in this model would be a critical step in translating this 
work into the clinic.  As an effective dose (per gram of mass) and route of administration have 
already been established in the zebrafish, experimental procedures could be easily adapted to the 
murine system.  With an expected time frame, type, and level of response known, efficient 
experiments could be designed to accommodate the more limited numbers of mice available 
compared to zebrafish.  Preliminary data from further analysis of the data comparing various 
differentiation stages of fetal and adult human CD34+ cells [261] shows that TRβ is one of the 
most differentially regulated genes, with significantly higher expression in the adult state (Jian 
Xu, personal communication). As differentiated fetal and adult CD34+ cells expressed fetal and 
adult globin respectively, this difference may suggest that receptor expression, at least partially, 
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controls the effect of the thyroid hormone receptor pathway on globin expression and that TRβ is 
the thyroid hormone receptor that regulates globin switching in mammals.  To investigate the 
role of TRβ further, the TRβ knockout mouse could be used.  While no hematopoietic phenotype 
has been observed in the mouse [160–162], no work has been published examining globin 
switching.  The lack of a hematopoietic phenotype may be advantageous as it may indicate that 
specific targeting of TRβ may limit side effects.  Peripheral blood and bone marrow from 
knockout mice and wild type controls could be compared for expression of all globin genes at the 
mRNA and protein levels in the embryonic and adult stages to determine if the absence of this 
receptor alters normal globin expression.  If a phenotype was observed, the mouse could be 
crossed into the transgenic mouse containing the human globin locus [52] to determine if the 
expression of the human globin genes are altered.  If these results indicate that decreased levels 
of TRβ in the adult stage increase the expression of fetal globin, drugs specifically targeting TRβ 
could be tested in mouse models of sickle cell disease [102,103].  If these results then 
demonstrate that modulation of TRβ helps to affect the phenotype and/or ameliorate the 
symptoms of sickle cell disease, further translation of these drugs could be pursued for use in the 
clinical treatment of patients.            
Conclusion  
This thesis establishes the zebrafish as a model system for the study of hemoglobin 
switching and identified the Wnt and thyroid hormone receptor pathways as regulators of the 
process.  By fully annotating all the globin genes on both globin loci and precisely determining 
the developmental timing of the two globin gene switches, it was possible to use the zebrafish to 
screen for agents that could alter the normal functioning of this process.  After completing both a 
morpholino knockdown and chemical screen, two pathways were identified: the Wnt pathway 
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and the thyroid hormone receptor pathway.   Further work showed that the thyroid hormone 
receptor pathway modulated both mRNA and protein expression in embryos and adults.  
Mammalian cell culture experiments demonstrated the conserved nature of this role, which 
potentially opens up opportunities to explore therapeutics for hemoglobinopathies.  The 
techniques, reagents, and strategies developed here can be utilized in future screens and 
additional work to identify and investigate other aspects of globin gene regulation.  This thesis 
can serve as the basis for the future study of hemoglobin switching in the zebrafish, the study of 
the Wnt and thyroid hormone receptor pathways in globin gene regulation, and as a potential 
new line of investigations in hemoglobinopathy therapies.   
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